Compréhension du mécanisme d'activation du facteur de transcription DntR par cristallographie aux rayons X et diffusion des rayons X aux petits angles by Lerche, Michael
HAL Id: tel-01555467
https://tel.archives-ouvertes.fr/tel-01555467
Submitted on 4 Jul 2017
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Elucidating the activation mechanism of the
transcription factor DntR using X-ray crystallography
and small angle X- ray scattering
Michael Lerche
To cite this version:
Michael Lerche. Elucidating the activation mechanism of the transcription factor DntR using X-ray
crystallography and small angle X- ray scattering. Biomolecules [q-bio.BM]. Université de Grenoble,
2014. English. ￿NNT : 2014GRENV013￿. ￿tel-01555467￿
 
Université Joseph Fourier / Université Pierre Mendès France /  
Université Stendhal / Université de Savoie / Grenoble INP  
THÈSE 
Pour obtenir le grade de 
DOCTEUR DE L’UNIVERSITÉ DE GRENOBLE 
Spécialité : Biologie Structurale et Nanobiologie  
Arrêté ministériel : 7 août 2006 
 
Présentée par 
Michael LERCHE 
 
Thèse dirigée par Gordon LEONARD 
codirigée par Cyril DIAN 
 
préparée au sein du European Synchrotron Radiation Facility   
dans l'École Doctorale Chimie et Science du Vivant 
 
Elucidating the activation mechanism of 
the transcription factor DntR using X-ray 
crystallography and Small Angle X-ray 
Scattering 
 
Compréhension du mécanisme 
d’activation du facteur de transcription 
DntR par cristallographie aux rayons X et 
diffusion des rayons X aux petits angles 
 
Thèse soutenue publiquement le 18 Julliet 2014, 
devant le jury composé de :  
Mr. Serge PEREZ  
CERMAV Grenoble, Président 
Mme Nushin AGHAJARI 
IBCP Lyon, Rapporteur 
Mr Louis RENAULT 
CNRS Gif-Sur-Yvette, Rapporteur 
Mr Frank GABEL 
IBS Grenoble, Membre 
Mme Nicole THIELENS 
IBS Grenoble, Membre 
Mr Cyril DIAN 
IMAXIO Lyon, Membre 
Mr Gordon LEONARD 
ESRF Grenoble, Membre 
 
1 
 
Acknowledgements 
 
First things first, a big thanks to Gordon and Cyril for letting me work on the DntR project. In 
particular a great thanks to Gordon for always being present with advice and encouragement while 
still allowing me to work as independently as I could have wanted. But mainly for always caring for 
both the project and me, it has really been a pleasure, thank you! 
Thanks to everyone in the ESRF structural biology group and in particular to past and present 
members of the CIBB laboratory for providing a great working environment, which I was so happy to 
be a part of. 
Thanks to the members of my thesis committee, in particular Chloe and Adam for willing or 
unwillingly accepting to be hassled with questions. 
Thanks to Marie for joining in on the DntR project and being a pleasure to work with.  
Tak til familie og venner i Danmark der paa trods af afstand tog sig til at besoge mig, forblev en del af 
mit liv igennem de sidste tre aar og altid var parate til at stille en seng, sofa eller bjornebryg til 
raadighed naar jeg kom forbi Danmark. 
Thanks to the original lab core crowd of Erika, Tobias and Morgane who were always there for 
camping, movies, skiing, dinners, parties, hiking, etc, and for support in both the good times and the 
other ones. 
Thanks to the later additions of Alex, Benoit, Taiana, Ottilie, Gautier and Catarina for joining in. 
Thanks to Gaëlle for daily coffees and running trips and for without whom this thesis would never 
have been completed. 
 
Thanks to everyone who took part in making these last three years of my life unforgettable, I’ll miss 
you all terribly.
 
2 
 
Table of Contents 
 
Aknowledgements ...................................................................................................................... 1 
Table of Contents ....................................................................................................................... 2 
Popularized summary ................................................................................................................. 5 
Résumé de these vulgarise ......................................................................................................... 5 
Abstract ...................................................................................................................................... 6 
Résumé ....................................................................................................................................... 8 
Abbreviations ........................................................................................................................... 10 
List of Figures ............................................................................................................................ 12 
List of Tables ............................................................................................................................. 16 
1. Introduction .......................................................................................................................... 17 
1.1 Transcription .................................................................................................................. 17 
1.2 Transcription factors ...................................................................................................... 18 
1.3 LysR type transcription factors ....................................................................................... 21 
1.3.1 Transcriptional regulation by LTTRs ........................................................................ 23 
1.3.2 The structure of LTTR proteins ................................................................................ 25 
1.3.3 The LTTR DNA Binding Domain. .............................................................................. 29 
1.3.4 LTTR Inducer Binding Domains ................................................................................ 33 
1.3.5 The crystal structure of full lengths LTTRs .............................................................. 37 
1.3.6 Non tetrameric LTTRs .............................................................................................. 40 
1.4 The LysR transcriptional regulator DntR ........................................................................ 40 
1.4.1 The structure of DntR .............................................................................................. 43 
1.4.1.1 Inducer-bound DntR ......................................................................................... 46 
1.5 The activation of LTTRs................................................................................................... 47 
1.6 Aim of thesis ................................................................................................................... 49 
2. Materials and methods ........................................................................................................ 51 
2.1 Expression and purification ............................................................................................ 51 
2.1.1 Wild type DntR (DntR-His6) ..................................................................................... 51 
2.1.2 H169TDntR-His6 ....................................................................................................... 56 
2.1.2.1 Mass spectrometry ........................................................................................... 58 
 
3 
 
2.1.3 ∆N90DntR and ∆N90H169TDntR............................................................................. 59 
2.2 pDnT ............................................................................................................................... 60 
2.3 Crystallization ................................................................................................................. 63 
2.3.1 DntR-His6 ................................................................................................................. 63 
2.3.2 H169TDntR-His6 ....................................................................................................... 63 
2.3.3 Salicylate-bound DntR-His6 ..................................................................................... 63 
2.3.3.1 High throughput crystallization trials ............................................................... 66 
2.3.4 Crystal data collection and refinement ................................................................... 66 
2.3.5 Thermofluor assays ................................................................................................. 68 
2.4 Small Angle X-ray Scattering (SAXS) ............................................................................... 68 
2.4.1.1 ∆N90DntR-His6 and ∆N90H169TDntR-His6 ...................................................... 68 
2.4.1.2 DntR-His6 .......................................................................................................... 70 
2.4.1.3 H169TDntR-His6 ................................................................................................ 71 
2.4.2 HPLC-coupled SAXS experiments ............................................................................ 71 
2.4.3 SAXS Data analysis ................................................................................................... 75 
2.4.3.1 Ab initio modelling ........................................................................................... 75 
2.4.3.2 Rigid body modelling ........................................................................................ 75 
2.5 Figure preparation .......................................................................................................... 77 
3 Results ................................................................................................................................... 78 
3.1 apo-DntR ........................................................................................................................ 78 
3.1.1 The crystal structure of apo-DntR ........................................................................... 78 
3.1.2 Small Angle X-ray Scattering analysis apo-DntR ..................................................... 86 
3.1.2.1 ab initio modelling ............................................................................................ 88 
3.1.2.2 Rigid body modelling ........................................................................................ 91 
3.2 H169TDntR ..................................................................................................................... 95 
3.2.1 Crystallization of H169TDntR .................................................................................. 95 
3.2.2 Small Angle X-ray Scattering analysis H169TDntR ................................................ 100 
3.2.2.1 Molecular envelopes of the solution structures of apo-H169TDntR ............. 102 
3.2.2.2 Comparison of the results of SAXS experiments concerning apo-DntR and apo-
H169TDntR ................................................................................................................. 105 
3.3 Conclusions on inducer-free DntR................................................................................ 105 
3.4 Small Angle X-ray Scattering analysis of DntR in complex with salicylate ................... 106 
 
4 
 
3.4.1 Solution structure of DntR pre-incubated with 100 µM salicylate ....................... 110 
3.4.2 Rigid body modeling .............................................................................................. 110 
3.4.3 Conclusions ............................................................................................................ 115 
3.5 HPLC-coupled SAXS ...................................................................................................... 115 
4 Discussion ............................................................................................................................ 120 
4.1 Summary of results ...................................................................................................... 120 
4.1.1 X-ray crystallography ............................................................................................. 120 
4.1.1.1 apo-DntR ........................................................................................................ 120 
4.1.1.2 H169TDntR ..................................................................................................... 120 
4.1.2 SAXS ....................................................................................................................... 121 
4.1.2.1 apo-DntR ........................................................................................................ 121 
4.1.2.2 H169TDntR ..................................................................................................... 121 
4.1.2.3 holo-DntR ....................................................................................................... 122 
4.1.2.4 Gel filtrated samples ...................................................................................... 122 
4.2 The inactive and active states of DntR ......................................................................... 123 
4.3 The activation of LTTR proteins .................................................................................... 128 
4.4 Future work. ................................................................................................................. 130 
Reference list .......................................................................................................................... 131 
5. Appendix: Small Angle X-Ray Scattering ............................................................................ 139 
5.1 Principles ...................................................................................................................... 139 
5.1.1 Scattering intensities ............................................................................................. 140 
5.2 Rg and I(0) ..................................................................................................................... 142 
5.2.1 Considerations ....................................................................................................... 143 
5.3 Pair distribution function (P(r)) .................................................................................... 143 
5.3.1 Considerations ....................................................................................................... 144 
5.4 Ab initio modeling ........................................................................................................ 145 
5.4.1 Considerations ....................................................................................................... 147 
5.5 CRYSOL fitting of experimental and theoretical scattering curves .............................. 148 
5.6 Rigid body modeling ..................................................................................................... 148 
 
  
 
5 
 
Popularized summary 
 
Proteins are an essential part of life and are responsible for a wide array of functions. The 
ability to produce the right protein in a given situation is a prerequisite for the survival of any 
organism. The production of proteins by organisms thus needs to be highly regulated.  
In all organisms the initial step in protein production involves converting genomic 
information, contained within their DNA, into a blueprint (known as messenger RNA, mRNA) 
for a specific protein. This process is known as transcription and is regulated by a type of 
proteins called transcription factors. In order to understand the mechanism of this 
regulation it is essential to know the three dimensional structure of transcription factors. 
This thesis work utilized the synchrotron based techniques X-ray crystallography and Small 
Angle X-ray Scattering to investigate the structure of the transcription factor DntR in order to 
elucidate how its activation regulates gene transcription and thus protein production. 
Résumé de thèse vulgarisé 
 
Les protéines sont des élements essentiels à la Vie et ont une large gamme de fonctions. La 
faculté de produire la bonne protéine dans la bonne situation est un pré-requis à la survie de 
tout organisme, et cette production nécessite une régulation stricte et coordonnée. 
Dans tous les organismes, l’étape initiale de la synthèse de protéines implique de copier 
l’information génétique codée par un géne contenu dans l’ADN en la convertissant en ARN 
messager. Ce procédé est appelé transcription et est régulé par différentes protéines qui 
comprennent les facteurs de transcription. La connaissance de la structure tridimensionnelle 
d’une protéine est souvent essentielle pour comprendre sa fonction, son mécanisme 
d’action et sa régulation à l’échelle moléculaire. 
Ce travail de thèse a consisté à étudier la structure du facteur de transcription DntR et de 
comprendre comment son activation régule la transcription, en utilisant les techniques 
complémentaires de cristallographie aux rayons X et de diffusion de rayons X aux petits 
angles.  
 
6 
 
Abstract 
 
LysR type transcriptional regulatory (LTTR) proteins are the largest family of transcription 
factors amongst prokaryotes. In spite of the size of the family, structural information on full-
length constructs of these proteins is very limited as they are often insoluble and very 
difficult to crystallize. From the few existing crystal structures, coupled with other 
biophysical evidence, it is known that the proteins mainly associate as homotetramers 
comprising a dimer of dimers. The dimers associate through large C-terminal domains in a 
“head-to-tail” fashion and are connected “head-to-head” through their N-terminal domains 
and the resulting homotetramers are activated by the binding of inducer molecules. Each C-
terminal domain contain an inducer binding cavity (IBC) and is denoted an inducer binding 
domain (IBD), while the N-terminal dimers each bind a region of DNA via a winged helix-
turn-helix (wHTH) motif. 
Unlike other transcription factors, LTTR proteins do not regulate expression by associating or 
disassociating with DNA. They bind to DNA in both their active and inactive states and the 
current consensus is that they regulate gene expression through large conformational 
changes that relax the bending of bound DNA. However, to this date, no crystal structures of 
a full length homotetrameric LTTR in both an active and inactive conformation exists, and 
thus their mechanism of transcriptional regulation remains structurally uncharacterized. 
The work described in this thesis has used the LTTR DntR as a model protein to futher 
structurally characterize the activation mechanism of LTTR proteins. The first crystal 
structure of apo-DntR is presented as is the crystal structure of H169TDntR, a mutant which 
shows activity in the absence of an inducer molecule. Thermofluor assays performed on this 
mutant, show that it has a melting temperature similar to that of inducer bound DntR. 
Comparison of these crystal structures with the crystal structure of salicylate-bound DntR 
reveals that the protein in its apo-state adopts a compact IBC, which precludes the binding 
of an inducer molecule. Despite the evidence of thermofluor assays, the crystal structure of 
H169TDntR is very similar to that of apo-DntR suggesting that crystal packing effects impose 
strong limitations on the use of crystallography to elucidate the active and inactive 
conformations of DntR. Small Angle X-ray Scattering (SAXS) was thus used to study the 
structure of DntR in solution. 
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SAXS study reveals that in solution DntR in its inactive apo-state is found in a different 
conformation compared to that seen in its crystal structure. While maintaining a compact 
tetrameric C-terminal core the DNA binding wHTH dimers pack much closer to this than seen 
in the crystal structure and adopt a conformation that would result in much higher bending 
of bound DNA than previously postulated. 
SAXS studies of the constitutively active H169TDntR mutant confirm, as thermofluor assays 
had suggested, that in solution the structure of this protein is markedly different from its 
crystal structure. Indeed the solution structure of H169TDntR appears very like that of open-
form homotetramers seen in the crystal structure of TsaR. This same effect was observed in 
solution scattering studies of inducer bound-and thus activated, DntR. 
The work presented in this thesis thus appears to confirm, as previously hypothesized, that 
upon activation DntR, and presumably all homotetrameric LTTRs, undergo a conformational 
change from a compact, to a much more open form that allows the relaxation of the bound 
DNA promoter region, exposing it to solvent and allows RNA polymerase access and thus 
initiate transcription. 
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Résumé 
 
Les protéines régulatrices de la transcription de type LysR (LTTR) appartiennent à la plus 
grande famille de facteur de transcription (FT) chez les procaryotes. Malgré l’importance de 
cette famille, il existe peu de données structurales sur les LTTRs car ces FTs sont souvent 
insolubles et difficiles à cristalliser. Les quelques structures tridimensionnelles existantes et 
les différentes études biochmiques menées jusqu’à présent ont montré que ces FTs 
s'associent principalement sous forme d’homotétramère comprenant un dimère de dimères. 
Chaque dimère s’assemble en « tête-bêche » par un large domaine C-terminal. Ces dimères 
s’associent à leur tour par leurs domaines N-terminaux formant deux dimères en « tête-à-
tête ». L’homotétramère ainsi formé est activé par la liaison de molécules effectrices dans 
une cavité (Inducer Binding Cavity : IBC) localisée dans le domaine C-terminal, nommé 
domaine de liaison à l’inducteur (Inducer Binding Domain : IBD). Chacuns des dimères 
formés par les domaines N-terminaux se lient à une région de l'ADN par leurs motifs Hélice-
Tour-Hélice ailés (winged HTH). 
Contrairement aux autres facteurs de transcription, les LTTRs ne régulent pas l'expression 
protéique par une simple association ou dissociation avec l'ADN. Ces FTs sont 
continuellement liés à l'ADN dans leur état actif et inactif. Il existe un consensus sur la 
manière dont les LTTRs régulent la transciption. Cette régulation repose sur d’importants 
changements conformationnels qui induisent le relâchement de la courbure de l'ADN en 
amont du promoteur du gène régulé. À ce jour, aucun membre de la famille des LTTRs n’a vu 
ses deux conformations, active et inactive, déterminées par cristallographie aux rayons X. 
Par conséquent, leur mécanisme moléculaire de régulation transciptionelle reste à 
caractériser. 
Le travail décrit dans cette thèse concerne un membre de la famille des LTTRs, DntR. La 
structure cristalline de DntR sous forme apo ou inactive est présentée ainsi que la structure 
du mutant H169T-DntR, qui est constamment actif en absence de molécules effectrices. 
L’analyse par fluorimétrie différentielle à balayage (DSF ou TSA) montre que la température 
de dénaturation de ce mutant autoinducteur est similaire à celle obtenue avec DntR liée à 
une molécule inductrice, le Salicylate. La comparaison des structures obtenues avec celles de 
l’IBD de DntR lié au Salicylate révèle que la protéine dans son état apo arbore une IBC 
 
9 
 
reserrée, qui ne favorise pas la liaison de molécules inductrices. Malgré l’évidence des 
informations apportées par le TSA, la structure du mutant autoinducteur H169T-DntR 
adopte, elle aussi, une structure quaternaire identique à DntR sous forme apo. La nécéssité 
de la création de contacts lors de l’empilement cristallin impose d'importantes limitations à 
l’utlisation de la cristallographie aux rayons X pour clarifier les conformations active et 
inactive de DntR. Pour se libérer de ces restrictions, nous avons étudié la structure de DntR 
en solution par méthode de diffusion des rayons X aux petits angles (SAXS). 
L’étude SAXS effectuée sur DntR montre que dans son état inactif, la conformation apo 
adopte une conformation compacte légérement différente de celle observée dans la 
structure cristalline. Dans cette structure en solution, les dimères de wHTHs sont accolés au 
corps compact formé par les domaines C-terminaux et leurs orientations s’en trouvent 
modifiées. Le rapprochement des domaines de liaisons à l’ADN suggére que la coubure de 
l’ADN induite par DntR dans  cette conformation serait plus importante que celle postulée 
précédemment. 
Les études SAXS menées sur le mutant autoinducteur H169TDntR confirme l’analyse 
effectuée par TSA et montre que la structure quaternaire de ce mutant en solution est 
différente de celle obtenue dans le cristal. En effet, la structure en solution de H169TDntR 
est très similaire à la conformation ouverte de l’homotétramère observée dans la structure 
cristalline de TsaR. Cette conformation ouverte est aussi observée par méthode de diffusion 
des rayons X aux petits angles pour DntR activée en présence de molécules inductrices. 
Les études SAXS sur DntR sauvage et son mutant autoinducteur H169TDntR en solution 
confirment l’hypothèse du mécanisme d’activation postulée pour la famille des LTTRs. Lors 
de la liaison d’une molécule effectrice, l’homotetramère subirait un important changement 
de conformation traduit par le repositionnement des domaines de liaison à l’ADN d’une 
forme compacte vers une forme ouverte induisant le relâchement de la courbure de la 
molécule d’ADN liée. Ce relâchement favoriserait l’accés de l’ARN polymerase aux régions 
promotrices et ainsi, l’initiation de la transcription de l’opéron régulé. 
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LB  Luria broth medium 
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1. Introduction 
1.1 Transcription 
 
Transcription is the first step in gene expression in which a segment of DNA is copied into an 
mRNA transcript that is then decoded by ribosomes to produce proteins. The principal 
enzyme involved in the process of transcription is RNA polymerase, which catalyzes the 
polymerization of ribonucleoside 5′-triphosphates in the 5′ to 3′ direction. RNA polymerase 
initially binds to a promoter region located upstream of the gene to be transcribed (Cramer 
et al., 2001; Gnatt et al., 2001). The crystal structure of RNA Polymerase II from 
Saccharomyces cerevisiae is shown in Figure 1.1. 
 
Figure 1.1: The crystal structure of RNA polymerase-II. A: The crystal structure of RNA polymerase II with the 
proposed position of bound DNA. As published by (Cramer et al., 2001). B: Electron density for a DNA-RNA 
hybrid bound to RNA-polymerase. The location of the active site metal A is indicated. As published by (Gnatt et 
al., 2001). 
A major strength of prokaryotes is their ability to regulate and fine tune gene expression to 
respond to internal and external stimuli. The fact that gene expression was regulated was 
discovered in the late 1950s during studies of the induction of the lac operon (Jacob and 
Monod, 1959) and the control of the lytic-lysogenic cycle in λ-phage infection (Ptashne, 
1965). Multiple subsequent studies showed that there were generalities as to how cells 
coupled various stimuli with gene expression (Burgess et al., 1969; Stevens and Rhoton, 
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1975), but mechanisms via which gene expression could be regulated, were not elucidated 
until the first crystallographic structures of so-called transcription factors (proteins that 
regulate gene expression) became available (McKay and Steitz, 1981; Weber and Steitz, 
1987) (Figure 1.2). 
 
Figure 1.2: The crystal structure of the Escherichia Coli catabolite activator protein (CAP), PDB: 3GAP. The 
protein associates as a dimer (monomers shown in green and blue) with cyclic AMP binding sites located in the 
C-terminal switch domain (light blue and light green) while the N-termini (dark blue and dark green) were 
presumed to bind DNA (Weber and Steitz, 1987). 
1.2 Transcription factors 
 
As shown in Figure 1.2, transcription factors (TFs) require at least two domains to allow them 
to function as regulatory proteins (Balleza et al., 2009). One domain serves as switch, 
responding to ligand binding, protein-protein interactions or physiochemical signals such as 
a change in pH or temperature (Martínez-Antonio et al., 2006; Ptashne and Gann, 2001). The 
second domain directly binds a target DNA sequence close to a promoter region and will 
respond according to whether the switch domain is activated/inactivated (Balleza et al., 
2009). In bacteria the DNA binding domain usually consists of the helix-turn-helix (HTH) 
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motif which has been identified in 95% of all prokaryotic DNA binding proteins (Huffman and 
Brennan, 2002). The two domains required by a TF can be contained either within a single 
protein (one-component system) or two different proteins (two-component system) (Ulrich 
et al., 2005). In the latter the switch domain is usually located in a membrane-linked 
multidomain sensor kinase which can then communicate, through phosphorylation 
cascades, with its cytosolic DNA binding partner protein (Mascher, 2006). The two types of 
TFs are schematized in Figure 1.3. 
 
Figure 1.3: Schematics showing one and two component regulatory systems. A one-component system (left) 
is a single protein that contains both switch (red) and output (green) domains. Two-component signal 
transduction systems contain their switch and output domains in different proteins which communicate via 
phosphotransfer domains (blue and orange). Figure from adapted from (Ulrich et al., 2005). 
 
Figure 1.4: Examples of positive and negative transcriptional regulation. Top left: A positive regulator of 
transcription (orange) binds upstream of the promoter region and helps to recruit RNA polymerase (green). 
Top Right: A negative regulator (orange) binds on the promoter region and blocks RNA polymerase (red) from 
binding thus preventing transcription. Bottom: A transcription factor (orange) binds in the intergenic region 
between divergently transcribed genes and recruits RNA polymerase (green) allowing for the transcription of 
one gene, while RNA polymerase binding to the second promoter region, and thus transcription of the second 
gene, is blocked. 
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TFs can be divided into two further subcategories: negative and positive regulators (Figure 
1.4, top). A negative regulator will usually bind DNA at, or very near to, a promoter region 
and thereby sterically prevents RNA polymerase from accessing the DNA (Collado-Vides et 
al., 1991). Positive regulators bind upstream of the promoter region and help to recruit the 
polymerase (Madan Babu and Teichmann, 2003). Some transcription factors may perform 
both roles, binding to the intergenic region between divergently transcribed genes, affecting 
regulation of both of them in different manners (Figure 1.4, bottom) (Balleza et al., 2009). 
Bacterial TFs usually operate as homomultimers of various orders and only rarely as 
heteromultimers (Goulian, 2004). TFs are promiscuous to various degrees and can be 
classified as either Local or Global TFs: Local TFs tend to bind only to one specific DNA 
sequence while Global TFs can bind to a larger ensemble of DNA regions (Lozada-Chávez et 
al., 2008; Martínez-Antonio et al., 2006) and thus be involved in the regulation of more than 
one operon. Gene expression is also affected by the relationship between the affinity of the 
TF to the DNA binding site and the relative expression the TF within the cell. In fact, a low 
affinity TF may, at higher concentrations, regulate expression of genes normally regulated by 
higher affinity TFs. TFs can also perform a dual role based on concentration in the cell (Figure 
1.5). If a gene contains a binding site inside the promoter with a weak binding affinity and a 
binding site upstream of the promoter of strong binding affinity, at low concentrations the 
TF will only bind the high affinity site and thus promote transcription, at higher 
concentrations the low affinity binding site will also be occupied and transcription will thus 
be blocked (Balleza et al., 2009). 
A strong correlation has been established between the relative stability of the ecological 
niche that a bacterium occupies and the proportion of transcriptional regulators, specifically 
TFs, encoded in a genome. Bacteria that live in relatively stable niches, such as intracellular 
pathogens, endosymbiots and extremophiles, have undergone a reduction in genome size 
and harbour less TFs per gene. In contrast, bacteria that are exposed to extreme variation in 
their environment, such as free-living organisms and bacteria that colonise plants or infect 
animal tissues, possess large genomes with a larger TF-to-gene proportion. The evolutionary 
response produced by prokaryotes to a changing environment thus appears to rely to a large 
extent on transcriptional control of gene expression by TFs (Cases and de Lorenzo, 2005; 
Cases et al., 2003). 
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Figure 1.5: Examples of gene regulation via TF concentration. Top: A schematic of a gene containing two 
binding sites for a TF. One is a high affinity site (red) located upstream of the promoter, the other a low affinity 
site (purple) located within the promoter region. When the TF is present within the cell at low concentrations 
only the high affinity site will be occupied (bottom left) and the TF will act as a positive regulator. At higher 
concentrations the TF will also bind to the low affinity site (bottom right) and act as a negative regulator. 
1.3 LysR type transcription factors 
 
LysR-type transcriptional regulators (LTTR) were initially documented in 1988 by Henikoff et 
al (Henikoff et al., 1988) who, in various organisms (Escherichia coli, Salmonella enterica, 
Rhizobium and Enterobacter cloacae), identified regulatory proteins which, based on 
sequence homology and the predicted secondary structure of their DNA binding domains, 
could be denoted as a distinct class of bacterial transcriptional regulators. The group is 
named after one of its earliest identified members, LysR, which controls the transcription of 
the lysA operon that codes for enzymes which catalyze the decarboxylation of 
diaminopimelate to produce lysine (Stragier and Patte, 1983). LTTRs are present in a wide 
and diverse range of prokaryotes, suggesting their progenitor arose early in prokaryote 
evolution (Schell, 1993). Based on genome sequences more than 800 LTTRs have now been 
identified and the group comprises the largest known family of prokaryotic transcriptional 
regulators, corresponding to about 20% of all known bacterial TFs (Pareja et al., 2006). 
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The genes regulated by LTTRs usually express enzymes involved in basic metabolic pathways, 
but may also play a role in several other functions such as cell division, motility and various 
stress responses (reviewed in Maddocks and Oyston, 2008). By way of an example, the 
diversity of gene regulation by LTTRs in S. enterica is illustrated in Figure 1.6. Despite the size 
of the LTTR family, the variety of functions of the gene products of which they regulate 
expression, and a relatively low sequence identity (Table 1.1), the family shares a high 
degree of structural identity (Maddocks and Oyston, 2008) and LTTRs are thus expected to 
regulate transcription in a similar manner. 
 
 
Figure 1.6: The diversity of gene products regulated by LTTR proteins in S. Enterica. Of the 49 reported LTTR 
proteins in S. enterica, the roles of 24 have been characterized. Figure as published by (Lahiri et al., 2009). 
 
 
BenM CatM CbnR CynR OxyR TsaR CysB PA01 AphB RovM MetR 
BenM 
           CatM 58.75 
          CbnR 29.35 27.99 
         CynR 24.16 24.16 25.09 
        OxyR 21.00 20.40 20.27 24.08 
       TsaR 20.55 19.52 20.42 23.21 20.95 
      CysB 19.00 19.40 17.87 23.08 19.54 20.61 
     PA01 26.17 26.17 22.41 20.13 19.67 18.71 22.26 
    AphB 20.21 19.16 18.25 19.51 13.45 18.34 14.88 19.45 
   RovM 18.66 19.79 20.07 22.78 18.28 19.06 19.59 18.82 17.02 
  MetR 21.40 21.48 17.59 19.13 18.36 17.69 19.02 22.52 15.07 17.87 
 DntR 15.07 15.07 14.19 17.18 15.70 17.53 15.02 14.81 11.90 18.02 17.23 
 
Table 1.1: Sequence identity matrix of LTTRs for which the crystal structures have been solved. The alignment 
was performed using the EMBL Clustalw2 server http://www.ebi.ac.uk/Tools/msa/clustalw2/. 
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1.3.1 Transcriptional regulation by LTTRs 
 
LTTRs were initially thought to share three main characteristics (Schell, 1993). They respond 
to exogenous inducer molecules; they bind a consensus operator sequence T-N11-A; they are 
divergently transcribed in relation to the regulator operon (i.e. they share a spatial gene 
organisation in which their encoding gene is located upstream and in the opposite direction 
of the regulated operon (Figure 1.7)). Divergently transcribed transcriptional units are 
believed to be more stable during genetic rearrangement and recombination and are 
believed to have advantages over non-divergent transcription as it only requires the 
maintenance of one protein to regulate two sets of genes (Beck and Warren, 1988; Reen et 
al., 2013a). 
Later studies reviewed by (Maddocks and Oyston, 2008; Momany and Neidle, 2012) also 
showed that LTTRs usually associate as tetramers (Ezezika et al., 2007; Monferrer et al., 
2010; Muraoka et al., 2003; Smirnova et al., 2004), bind to DNA through a wHTH domain 
(Alanazi et al., 2013a; McFall et al., 1997; Xu et al., 2001) and are activated via the binding of 
inducer molecules to a C-terminal domain (Ezezika et al., 2007; Monferrer et al., 2010; 
Smirnova et al., 2004). However, LTTRs which do not strictly follow these characteristics 
have been identified. Examples here include Neisseria Meningitidis OxyR which is activated 
by the breakage, caused by oxidative stress, of a disulphide cysteine bridge, rather than the 
binding of an inducer molecule (Choi et al., 2001), the newly identified Pseudomonas 
aeruginosa PA2206, which was shown not to be divergently transcribed (Reen et al., 2013b) 
and Neisseria Meningitidis CrgA which was shown to associate as an octamer (Section 1.3.5) 
(Sainsbury et al., 2009). 
LTTRs bind to two sites on DNA; the Repression (or Regulating) Binding Site (RBS) and the 
Activating Binding Site (ABS) (Figures 1.7, 1.8). The RBS is a 20-30 bp motif containing a 
ATAC-N7-GTAT repeat with the consensus LTTR binding motif T-N11-A located around 65 
bases upstream of the LysR gene (Schell, 1993). LTTRs bind the RBS in both the presence and 
absence of an inducer molecule allowing it to serve as an anchoring point (Schell, 1993). The 
repression of transcription of the Leers gene has been seen to be slightly lowered in the 
presence of an inducer molecule (Coco et al., 1993; van der Meer et al., 1991) but this does 
not however seem to be a general trend (Tropel and van der Meer, 2004). 
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Figure 1.7: The classical model of LTTR dependent transcriptional regulation. The lttr gene is transcribed when 
no LTTR protein is bound to the LTTR promoter region, ensuring a basal level of LTTR (yellow) within the cell. 
When a LTTR is bound to the RBS it inhibits auto expression. The LTTR binds upstream of the promoter region 
of the divergently transcribed target gene and upon the binding of an inducer molecule it activates 
transcription of the target gene. Figure adapted from (Maddocks and Oyston, 2008). 
 
The ABS contains no consensus sequence but was shown during studies of the binding of 
ClcR to the clcA gene, to shift from position -37 to -41 in the presence of an inducer molecule 
(McFall et al., 1997). LTTR tetramers bind both DNA sites simultaneously and, unlike other 
transcription factors, regulate transcription by undergoing conformational changes without 
changing their binding affinity. When binding to DNA in their inactive state LTTRs induce a 
bend in the DNA of the promoter region between 50o and 100o, preventing the binding of 
RNA polymerase. When a LTTR is activated this bend in the DNA relaxes to between 9o and 
50o exposing the promoter to the solvent, allowing RNA polymerase recruitment and thus 
transcription of the regulated gene (Figure 1.8) (Fisher and Long, 1993; Hryniewicz and 
Kredich, 1995; van Keulen et al., 1998; Parsek et al., 1995; Piñeiro et al., 1997; Toledano t al., 
1994; Wang et al., 1992). 
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Figure 1.8: A schematic showing the current model of LTTR transcriptional regulation. Two dimers of a LTTR 
bind to the RBS and ABS sites of the promoter region and associate to form a tetramer. This results in a bend in 
the DNA of between 50
o
 and 100
o
. Upon activation, the LTTR homotetramer undergoes a conformational 
change which causes a relaxation of the DNA bend, allowing RNA polymerase to bind. Figure adapted from 
(Maddocks and Oyston, 2008). 
 
1.3.2 The structure of LTTR proteins 
 
LTTRs comprise approximately 330 residues and generally form homotetramers in solution 
(Ezezika et al., 2007; Monferrer et al., 2010; Muraoka et al., 2003; Smirnova et al., 2004). In 
LTTR monomers a large C-terminal region contains the Inducer Binding/Switch Domain (IBD) 
while approximately 60 amino acids in the N-terminal domain forms the winged Helix Turn 
Helix (wHTH) region required for DNA binding (Momany and Neidle, 2012). The two domains 
are connected by a flexible linker helix region. The IBC consists of two Rossman fold like 
domains (RD1 and RD2) with the inducer binding cleft found (IBC) at their interface. A 
schematic of the domain structure of LTTR monomers is shown in Figure 1.9. 
 
 
Figure 1.9: The domain structure of LTTR monomers. The N-terminal DNA Binding Domain (DBD) is connected 
to the C-terminal IBD through a flexible linker helix.  
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The in vitro production of LTTR proteins is often made difficult by solubility issues (Ezezika et 
al., 2007; Xu et al., 2012), most likely caused by the vast array of oligomerisation schemes they 
can adopt at higher concentrations (Figure 1.10) (Ruangprasert et al., 2010). These can be 
overcome by truncating the protein leaving only the IBD (Momany and Neidle, 2012). Many 
structural studies of LTTRs have thus focused on the IBDs only. Table 1.2 shows the crystal 
structures obtained for LTTR proteins to date. 
 
 
 
Figure 1.10: Proposed oligomerisation schemes for the LTTR BenM. RD1 and RD2 of the IBD are denoted I and 
II. Multiple DntR monomers may have contacts through RD2 and thus create a chain of tetramers. The N-
terminal domain of a monomer in one chain may also associate with the N-terminal domain of a different chain 
Figure from (Ruangprasert et al., 2010). 
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Name (PDB ID) IBD only 
Full length 
protein 
Reference 
AphB: 
  
 
Full length (3SZP) 
 
X (Taylor et al., 2012) 
Full length N100E (3T1B) 
 
X (Taylor et al., 2012) 
BenM: 
  
 
Inducer binding domain at high pH (2F8D) X 
 
(Ezezika et al., 2007) 
Inducer binding domain (2F6G, 2F6P) X 
 
(Ezezika et al., 2007) 
Inducer binding domain in complex with benzoate (2F78) X 
 
(Ezezika et al., 2007) 
Inducer binding domain in complex with muconate (2F7A) X 
 
(Ezezika et al., 2007) 
Inducer binding domain R156H, T157S (2H9B) X 
 
(Craven et al., 2009) 
DBD domain in complex with DNA (4IHT) 
  
(Alanazi et al., 2013a) 
CatM: 
 
X (Muraoka et al., 2003) 
Inducer binding domain (2F7B) X 
 
(Ezezika et al., 2007) 
Inducer binding domain in complex with muconate (2F7C) X 
 
(Ezezika et al., 2007) 
Inducer binding domain R156H (3FLB) X 
 
(Craven et al., 2009) 
Inducer binding domain V158M (2H98) X 
 
To Be Published 
CbnR: Full length (1IZ1) 
 
X (Muraoka et al., 2003) 
CysB: 
  
 
Cofactor binding fragment (1AL3) X 
 
(Tyrrell et al., 1997) 
Inducer binding domain (4GWO) X 
 
To be Published 
CynR: Full length (3HFU)  X To be Published 
DntR: 
  
 
Full length In complex with thiocyanate (1UTH) 
 
X (Smirnova et al., 2004) 
Full length In complex with acetate (1UTB) 
 
X (Smirnova et al., 2004) 
Mutants F111L and Y110S,F111V (2UFY, 2UYE)  
 
X (Lönneborg et al., 2007) 
Inducer binding domain (2Y7R) X 
 
(Devesse et al., 2011) 
Inducer binding domain complex with salicylate (2Y7P) X 
 
(Devesse et al., 2011) 
MetR Inducer binding domain (4AB5) X 
 
(Sainsbury et al., 2012) 
OxyR: 
  
 
Oxidised form (1I6A) X 
 
(Choi et al., 2001) 
Reduced form (1I69) X 
 
(Choi et al., 2001) 
Reduced form from N. Meningitids (3JV9) X 
 
(Sainsbury et al., 2010) 
From porphyromonas gingivalis (3HO7) X 
 
(Svintradze et al., 2013) 
PA01: Inducer binding domain (3FZV) 
 
X To be Published 
RovM: Inducer binding domain (3ONM) X 
 
(Quade et al., 2011) 
TsaR: 
  
 
In complex with p-toluenesulfonate (3FXU) 
 
X (Monferrer et al., 2010) 
Inducer binding domain (3N6T) X 
 
(Monferrer et al., 2010) 
Inducer binding domain in complex with p-toluenesulfonate (3FXU) X 
 
(Monferrer et al., 2010) 
Un named (3KN3) X 
 
To be Published 
 
Table 1.2: Available crystal structures of LTTR proteins. The currently available crystal structures of LTTRs. PDB 
Ids are shown in parenthesis. 
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As can be seen in Table 1.2, BenM and TsaR are two particularly well studied LTTRs. BenM is 
a transcription factor from the soil bacterium Acinetobacter baylyi in which it regulates the 
transcription of genes, BenABCD, involved in the degradation of benzoate (Figure 1.11) 
(Collier et al., 1998). 
 
Figure 1.11: The pathway for the degradation of benzoate and anthranilate in the soil bacterium 
Acinetobacter bayly. BenM provides transcriptional regulation for all genes responsible for the breakdown. 
Figure as published by (Craven et al., 2009). 
  
TsaR regulates the tsa operon containing the tsaMBCD pathway responsible for the 
degradation of p-toluenesulfonate (TSA) and p-toluenecarboxylate (TCA) in Comanonas 
Testosterone (Figure 1.12) (Tralau et al., 2003). 
 
Figure 1.12: The pathway for the degradation of TSA and TCA in Comanonas Testosterone. TsaR provides 
transcriptional regulation for genes within the box R1 that are responsible for the breakdown of TSA and TCA. 
Figure as published by (Tralau et al., 2003). 
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1.3.3 The LTTR DNA Binding Domain. 
 
In the crystal structures of full-length LTTRs the DBD/linker helix domains of the LTTR 
monomers associate to form wHTH dimers that flank a central IBD tetrameric core (Figure 
1.13). The wHTH motif consists of three helices noted α1, α2 and α3. Upon contact with DNA 
the outer helix, α3, also known as the recognition helix, is embedded into the major groove 
of its target site and allows for the two remaining helices to have contact with the more 
distal parts of the DNA (Brennan, 1993). As shown in Table 1.3 and Figure 1.14 the 
DBD/linker helix domains of different LTTRs display a higher degree of sequence similarity 
than is observed for the full length proteins (see Table 1.1). 
 Recently two crystal structures of the BenM DBD/linker helix domain bound to DNA were 
solved (Alanazi et al., 2013a) (Figure 1.15). As can be seen from Figure 1.15, in these crystal 
structures the DBD/linker helix dimers are very similar in structure to those shown in Figure 
1.14, and bind DNA in such a way that the two recognition helices in the wHTH dimer occupy 
two consecutive turns of the major groove of the DNA. This is unlike what is observed for 
other transcriptional regulators where the two recognition helices of a dimer occupy a 
continuous region of the major groove (Xu et al., 2001). The crystal structures solved by 
(Alanazi et al., 2013a) described complexes with two different DNA fragments; the promoter 
regions for the two divergently transcribed genes benA (T-N11-A site: ATACTCCATAGGTAT) 
and catB (T-N11-A site: ATACCTTTTTAGTAT) and show only minor differences. In both cases 
27 amino acids of the BenM dimer make 36 contacts with the DNA duplex. The major 
interactions seen are between recognition helix α3 and the major grooves of the ATAC sites 
at either end of the DNA duplex while the wings of the wHTH domain interact with the minor 
groove. 
The crystal structure also shows that the recognition of the ATAC motifs is highly dependent 
on the conserved residue Ser33 (see Figure 1.15, bottom) which interacts with the methyl 
group of the thymidine base through its Cβ atom and forms, via its hydroxyl group, hydrogen 
bonds with the phosphate group of the ATAC 5’ adenosine residue. As can be seen in Figure 
1.14 S33 is generally conserved throughout LTTRs with its hydrogen binding properties 
maintained in CbnR and AphB where it is replaced with Threonine. The importance of S33 
for recognition of the ATAC site is underlined by the fact that the S33N mutation in OxyR 
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(Kullik et al., 1995) and corresponding mutations S34R in CysB (Colyer and Kredich, 1994) 
and S38P in GcvA (Jourdan and Stauffer, 1998) have been shown to abolish the DNA binding 
properties of these LTTRs. Other important residues in DNA recognition are P30, R34 and 
R53 (Alanazi et al., 2013a) which are all also well conserved amongst LTTRs (Figure 1.14). 
Based on the conservation of the critical amino acids in the BenM DBD it seems likely that 
the model of DNA binding observed for BenM is shared amongst all LTTRs. 
 
Figure 1.13: The crystal structure of dimeric DBD/linker helix domains of LTTR homotetramers. From crystal 
structures of (from left to right): Tsar (Monferrer et al., 2010), DntR (Smirnova et al., 2004), CbnR (Muraoka et 
al., 2003). 
  BenM CatM CysB PA01 TsaR AphB CbnR CynR OxyR RovM MetR 
BenM 
           CatM 72.41 
          CysB 37.21 39.53 
         PA01 37.93 39.08 32.18 
        TsaR 31.03 33.33 26.74 26.44 
       AphB 32.18 31.03 22.09 30.00 28.74 
      CbnR 39.08 37.93 27.91 34.48 35.63 31.03 
     CynR 40.23 37.93 29.07 31.03 33.33 29.89 42.53 
    OxyR 31.03 32.18 27.91 25.29 27.59 19.54 29.89 35.63 
   RovM 32.14 32.14 26.51 24.14 25.00 18.48 30.95 30.95 20.24 
  MetR 35.63 34.48 26.74 28.89 27.59 19.78 26.44 32.18 21.84 29.55 
 DntR 21.84 22.99 18.39 22.22 20.69 14.13 18.39 19.54 19.54 24.72 24.18 
 
Table 1.3: Sequence identity matrix of the N-terminal of LTTR proteins. The alignment was performed using 
the EMBL Clustalw2 server http://www.ebi.ac.uk/Tools/msa/clustalw2/. 
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Figure 1.14: Amino acid sequence alignment of the DBD/linker helix domains of various LTTRs. The regions 
forming the three α-helices in the wHTH bundle and the linker helix as determined by (Alanazi et al., 2013a) are 
shown. The alignment was performed using the EMBL Clustalw2 server 
http://www.ebi.ac.uk/Tools/msa/clustalw2/. Residues corresponding to BenM P30 (red), S33 (yellow) and R53 
(blue) are indicated. 
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Figure 1.15: The binding of a dimer of the BenM DBD linker helix domain to its promoter region DNA. Top: 
The crystal structure of the BenM dimeric DBD/linker helix domain bound to DNA as outlined in the main text. 
The recognition helices of the wHTH dimer interact with consecutive turns of the major groove of the DNA. 
Bottom: Specific interactions between α3 and the ATAC site as seen in the crystal structure reported by 
(Alanazi et al., 2013a). 
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1.3.4 LTTR Inducer Binding Domains 
 
The three dimensional structures of LTTR Inducer Binding Domains (IBDs) are well 
characterized and in spite of a relative lack of sequence identity (Table 1.4, Figure 1.16) they 
are structurally very similar (Craven et al., 2009; Devesse et al., 2011; Ezezika et al., 2007; 
Lönneborg et al., 2007; Muraoka et al., 2003; Sainsbury et al., 2012; Smirnova et al., 2004; 
Taylor et al., 2012; Tyrrell et al., 1997) comprising two globular Rossman-Fold like sub-
domains, denoted RD1 and RD2 linked by a hinge region (Figure 1.17, bottom). 
For LTTRs activated by inducer molecules, a conserved inducer binding site (IBC) is located 
between the two RD subdomains of the IBD close to the hinge region. The crystal structures 
of inducer-bound IBDs of DntR (Devesse et al., 2011) and BenM (Craven et al., 2009) are 
shown in Figure 1.17, bottom. 
  BenM CatM CbnR PA01 AphB CynR TsaR CysB OxyR RovM MetR 
BenM 
           CatM 53.24 
          CbnR 25.24 23.79 
         PA01 21.33 20.38 17.16 
        AphB 16.42 14.93 12.06 13.86 
       CynR 16.59 18.48 17.16 18.57 13.2 
      TsaR 17.56 14.63 15.27 15.94 12.76 20.98 
     CysB 11.27 12.74 14.15 19.16 10.95 22.64 17.79 
    OxyR 15.49 11.79 15.61 18.69 10.5 16.51 15.31 16.2 
   RovM 14.29 15.84 13.33 17.73 14.72 20.5 17.01 17.21 18.81 
  MetR 15.17 17.14 13.3 19.53 13 15.71 13.11 17.89 15.35 14.01 
 DntR 11.71 10.24 13.37 11.96 10.24 12.32 14.85 12.56 14.56 13.13 13.11 
 
Table 1.4: Sequence identity matrix of the C-terminal of LTTR proteins. The alignment was performed using 
the EMBL Clustalw2 server http://www.ebi.ac.uk/Tools/msa/clustalw2/. 
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Figure 1.16: Amino acid sequence alignment of the IBDs of selected LTTRs. The locations of the two RD sub-
domains are indicated. The alignment was performed using the EMBL Clustalw2 server 
http://www.ebi.ac.uk/Tools/msa/clustalw2/. 
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Figure 1.17: The crystal structures of the LTTR IBD monomer. Top: Orthogonal views of the structure of a LTTR 
IBD monomer. RD1 is shown in green, RD2 shown in yellow and the linker region shown in blue. The IBD shown 
is that seen in the crystal structure of RovM from (Quade et al., 2011). Bottom: Inducer-bound IBDs as seen in 
the crystal structures of the IBDs of DntR (left) (2Y7K) and BenM (right) (2F7A). For both proteins residues 90-
300 are shown. The inducer molecules salicylate and muconate respectively are shown in red and are bound in 
the conserved IBC. The two Rossman-like fold domains for each IBD are shown in different nuances. 
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Figure 1.18: The crystal structures of LTTR IBD dimers. From left to right: DntR (2Y7K) and BenM (2F7A). 
Residues 90-300 are shown. The two monomers comprising each dimer are shown in different nuances. 
In crystal structures of constructs consisting only of LTTR IBDs, two IBD monomers associate 
head-to-tail to form dimers (Devesse et al., 2011; Ezezika et al., 2007; Quade et al., 2011; 
Svintradze et al., 2013; Tyrrell et al., 1997) as depicted in Figure 1.18. 
However, in spite of the strong structural similarities shown in Figure 1.17 and 1.18, there 
are differences in how inducer molecules are bound by LTTR IBDs. Indeed, some show 
effector binding in sites other than the IBC. BenM activates gene expression both in the 
presence of benzoate and muconate and when both molecules are present they have a 
synergistic effect on transcriptional regulation, higher than their singular additive effects 
(Bundy et al., 2002). Structural studies of BenM identified muconate in the conserved LTTR 
IBC but showed benzoate to bind in a previously unobserved binding site as shown in Figure 
1.19 (Ezezika et al., 2007). When benzoate is bound in this site it enhances, through 
electrostatic interactions, the effect of muconate binding, thus explaining the synergistic 
effect of the two molecules on transcriptional regulation. 
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Figure 1.19: The crystal structure of a BenM monomer with both benzoate and muconate-bound. Benzoate is 
shown in black spheres and muconate is shown in grey spheres. As published by (Ezezika et al., 2007). 
 
1.3.5 The crystal structure of full length LTTRs 
. 
Despite difficulties in expression, purification and crystallisation caused by a tendency to  
aggregate (Section 1.3.2, Figure 1.10) (Ezezika et al., 2007; Xu et al., 2012), the crystal 
structures of some full length LTTRs have been obtained (Table 1.2). These generally show 
LTTRs to associate as homotetramers with a quaternary structure comprising a tetrameric 
core (resulting from the association of two “head-to-tail” IBD dimers) that are connected 
“head-to-head” through via the dimerisation of two DBD/linker helix domains (Figure 1.20). 
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Figure 1.20: Schematic of the crystal structure of a typical LTTR homotetramer. A LTTR tetrameric dimer of 
dimers. Each monomer is shown in different colours. The position of a DNA and Inducer binding domain are 
indicated. 
In various crystal structure analyses LTTR homotetramers have been observed in either 
“compact” (Muraoka et al., 2003; Smirnova et al., 2004) or “open” (Monferrer et al., 2010; 
Taylor et al., 2012) conformations as shown in Figure 1.21. The compact state is maintained 
through interactions between the C-terminal domains of the head-to-tail dimers. These 
interactions are abolished in the open state in which the tetrameric state is maintained only 
through “head-to-head” interactions between the DBD/linker helix domains.  
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Figure 1.21: Crystal structures of open and compact full length LTTR homotetramers. Top: CbnR, closed 
conformation (PDB 1IXC; (Muraoka et al., 2003)) PA01, closed conformation (PBD 3FZV). Bottom: TsaR, open 
conformation (PDB 3FZJ; (Monferrer et al., 2010)), AphB, open conformation (PDB 3T1B; (Taylor et al., 2012))  
Monomers are shown in colours consistent with the colour scheme used in Figure 1.20. 
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1.3.6 Non tetrameric LTTRs 
 
In 2009 the crystal structure of the LTTR CrgA was solved (Sainsbury et al., 2009). In the 
crystal CrgA presented itself as an octamer, also confirmed to be its oligomeric state in 
solution by analytical ultracentrifugation. This conformation gives rise to four dimeric DNA-
binding wHTH domains. However based on DNA footprinting studies the authors speculate 
that two octamers associate to form a dimer of octamers, binding DNA with one dimeric 
wHTH dimer per octamer and leaving the other three unoccupied (Figure 1.22) (Sainsbury et 
al., 2009). Since the publication of the article describing CrgA no other LTTR has been found 
to associate as an octamer (Momany and Neidle, 2012). Nevertheless, while CrgA is currently 
a singular case, its crystal structure shows that some variation may exist within the LTTR 
protein family.  
 
 
Figure 1.22: The proposed oligomersation and DNA binding scheme of CrgA. Figure as published by (Sainsbury 
et al., 2009). 
1.4 The LysR transcriptional regulator DntR 
 
Bacteria that inhabit sites polluted with chemicals that were not introduced into Nature until 
the onset of synthetic chemistry slowly evolve catabolic pathways for these xenobiotic 
compounds (Cases and de Lorenzo, 2005). 2,4 dinitrotoluene (DNT) is a synthetic soil 
 
41 
 
pollutant used in the production of polyurethane foams and in the production of the 
explosive TNT (Ju et al., 2007). DNTs are highly toxic, converting haemoglobin into 
methemoglobin, and have a threshold limit value of 1.5 mg/m3 (Center for Disease Control: 
http://www.cdc.gov/niosh/npg/npgd0235.html).  
Since the introduction of DNTs into the environment several species of soil bacteria have 
evolved pathways which allow them to use DNTs as a carbon and energy source (Johnson et 
al., 2002; Brüning et al., 2002). The evolution of such a novel degradation pathway requires a 
bacterium to overcome three problems: the shift of some of its current metabolic enzymes 
into a new pathway; the evolution of a regulatory device for the expression of the 
corresponding catalytic genes; the avoidance of stress caused by the substrate itself 
(Kivisaar, 2009). A bacterium on the evolutionary road to overcoming these problems is 
Burkholderia sp. strain (de las Heras et al., 2011; Suen and Spain, 1993) the genome of which 
contains genes coding for enzyme pathways that catabolise DNT all the way to pyruvate 
(Figure 1.23). The most critical step in the degradation process is the deoxygenation of DNT 
by the enzyme DntA in positions 4 and 5 to yield 4-Methyl-5-nitrocathecol. 
 
Figure 1.23: DNT degradation in Burkholderia sp. Clockwise from top left: The DNT deoxygenase (DntA) 
hydroxolates the aromatic ring of DNT at positions 4 and 5 yielding 4-methyl-5nitrocatechol. A mono 
oxygenation (DntB) subsequently removes the remaining nitro group and the product reduced to 2,4,5 
trihydroxytoluene (DntC). The ring is then cleaved through a CoA-dependent methylmalonate semialdehyde 
dehydrogenase (DntD). The product eventually converted into pyruvate. Figure from (de las Heras et al., 2011). 
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Figure 1.24: The arrangement of the catabolic genes in the DNT degrading pathway in Burkholderia sp. The 
gene encoding the transcription factor DntR is labelled R and is divergently transcribed of the dntA cluster. 
Figure from (de las Heras et al., 2011). 
 
Having solved the issue of establishing a new catabolic pathway the bacterium also requires 
a regulation mechanism for the pathway. The organization of genes related to the DNT 
catabolic pathway in Burkholderia sp. is shown in Figure 1.24. The transcription of the most 
critical component of the pathway is regulated by the LTTR DntR, placed divergently of the 
dntA gene. This placement would indicate that DntR will bind DNT as its inducer molecule 
and subsequently activate the transcription of the dntA genes. However, DntR is not 
activated by DNT but is strongly activated by the small molecule salicylate, an intermediate 
in the degradation pathway of naphthalene (Lönneborg et al., 2007; Smirnova et al., 2004). 
This indicates that although Burkholderia sp. has evolved the catabolic machinery for the 
degradation of DNT, the regulation of the pathway still has to be optimised. DntR thus 
represents an evolutionary snapshot of a TF on the way to proper transcriptional regulation 
(de las Heras et al., 2011). 
The arrangement of genes as shown in Figure 1.24 prompted studies aimed at using DntR as 
a biosensor for DNT. The premise of such a biosensor can be seen in Figure 1.25 (Ng and 
Forsman, 2000). This however will require the production of an engineered DntR with a 
modified specificity (i.e. activated specifically by DNT). While progress has been made in this 
area (Lönneborg et al., 2007, 2012) the idea of a DntR-based biosensor for DntR is very much 
at a preliminary stage and thus will not be further discussed here. 
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Figure 1.25: The premise of a biosensor for DNT. The gene transcription of a fluorescent protein such as gfp is 
placed downstream of the pDnT promoter and its transcription is thus under the control of DntR. In the 
presence of DNT DntR would be activated and allow the transcription of the fluorescent protein. Adapted from 
(Ng and Forsman, 2000). 
1.4.1 The structure of DntR 
 
DntR consists of 301 amino acids in which the 64 residue N-terminal DNA binding wHTH 
domain is linked to the C-terminal IBD by a linker helix about 20 amino acids in length (Figure 
1.26). Mobility shift assays confirmed that DntR binds DNA both in the absence and presence 
of an inducer molecule, salicylate, and that the binding of this inducer did not significantly 
change DNA binding affinity (Smirnova et al., 2004). This is compatible with the current 
model of activation in which LTTRs bind DNA both in the presence and absence of an inducer 
molecule, (see Figure 1.8). 
 
Figure 1.26: The domain structure of DntR. As for other LTTRs, DntR consists of a wHTH helix motif comprising 
three α-helices: α1, α2 and α3 joined to the IBD by a linker helix. The residues which form the IBC are shown in 
red. Domain structure as determined in (Smirnova et al., 2004). 
 
 
44 
 
 
Figure 1.27: The current available crystal structure of the full length DntR homotetramer. The monomers are 
shown in different colors. (A): Structure of the DntR tetrameric core based on the combination of two 
asymmetric units (PDB 1UTB). The DBD/linker helix domains for all four monomers were disordered. (B): Low 
level electron density of the DBD linker domains allowed the modelling of the positions of these domains to 
provide a model for the full length structure of DntR. (C): Two orthogonal views of the model of the structure 
of homotetrameric structure of full length DntR. (D): A theoretical model of DNA binding to a full length DntR 
tetramer. Figures from (Smirnova et al., 2004). 
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The crystal structures of full length DntR in complex with either acetate or thiocyanate were 
solved in 2004 (Figure 1.27A) (Smirnova et al., 2004). The N-terminal wHTH regions in both 
crystal structures reported very poor electron density and final models of full-length DntR 
monomers were based on fitting a homology model into this region for the two DntR 
molecules found in the asymmetric unit (Figure 1.27B) (Smirnova et al., 2004). 
As depicted in Figure 1.27C the crystal structures obtained showed a DntR homotetramer in 
a compact conformation. Comparison of the crystal structures of DntR and CbnR 
homotetramers revealed differences in the positions of the N-terminal wHTH domains 
(Figure 1.28) which were consistent with a relaxation of bound DNA. Based on this, and due 
to the fact that the IBCs in the crystal structures of DntR were occupied by either 
thiocyanate or by acetate, it was speculated that both acetate and thiocyanate mimicked the 
binding of salicylate in the IBC and that the crystal structure of DntR was that of a LTTR 
protein in its active state. 
 
Figure 1.28: Comparison of the crystal structures of DntR and CbnR homotetramers. The quarternary 
structure of full length homotetrameric DntR (left) and CbnR (right). As published by (Smirnova et al., 2004). 
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1.4.1.1 Inducer-bound DntR 
 
While Smirnova and colleagues (Smirnova et al., 2004) presumed that the binding of acetate 
or thiocyanate in the DntR IBC mimicked that of the natural inducer molecule, in order to 
further investigate the inducer binding properties of DntR a truncated DntR construct, 
∆N90DntR, consisting of the IBD only, was produced and crystallized in complex with the 
DntR effector molecule salicylate (Devesse et al., 2011). Truncating DntR at residue 90 
removes the linker helix and N-terminal wHTH domain, and changes quaternary structure 
from a tetramer to a dimer (Figure 1.18).  
The crystal structures obtained (Devesse et al., 2011) revealed two salicylate binding sites 
(Figure 1.29, top). The first is located in the conserved IBC between RD1 and RD2. In DntR 
the IBC is lined by hydrophobic residues that accommodate the aromatic ring of the inducer 
molecule, the hydroxyl and carboxyl groups of which form direct hydrogen bonds with Nε2 
of both H169 and H206 (Figure 1.29 Bottom, left). 
 
Figure 1.29: The crystal structure of salicylate-bound ∆N90-DntR (PDB 2Y7K). Top: The ∆N90-DntR monomer 
with two salicylate molecules bound (shown in black spheres). Bottom: Salicylate-bound in the conserved DntR 
IBC (left) and in the vicinity of secondary binding site (right). Figure from (Devesse et al., 2011). 
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Unexpectedly salicylate was also found to bind in a second site formed by residues close to 
the N- and C-termini of the ∆N90DntR construct (Figure 1.29, bottom right). Here binding of 
the aromatic ring is also stabilized by hydrophobic interactions and the salicylate molecule 
also forms a direct hydrogen bond with S95 and is involved in a solvent mediated interaction 
with the side chain of D284. 
The existence of a secondary binding site in full length DntR in vivo is questionable as its 
location in the ∆N90-DntR is occupied by F90 in the crystal structure of the full length 
protein. ITC studies (Devesse et al., 2011) on both ∆N90DntR and full-length DntR constructs 
neither confirmed nor rejected the idea of a secondary binding site as data could be 
successfully fitted against both one and two binding site models (Devesse et al., 2011). 
However, Devesse and colleagues also noted (Figure 1.30A) that the ∆N90DntR construct 
undergoes a significant conformational change only when salicylate is bound in both of the 
salicylate binding sites observed. The resulting conformation of the DntR IBD is very similar 
to that observed in the crystal structure of full length inducer-bound TsaR. Moreover, 
Devesse and Co-workers also noted that while the structures of apo-∆N90DntR and of 
∆N90DntR with salicylate bound only in the IBC were consistent with the formation of 
compact form DntR homotetramers, the conformation of ∆N90DntR with two salicylate 
molecules was not (Figure 1.30B). They therefore speculated (Figure 1.30 B), as suggested by 
(Monferrer et al., 2010) based on their crystal structure analysis of TsaR, that the active form 
of DntR, and thus all homotetrameric LTTRS, was the open conformation as seen in the 
crystal structure of inducer-bound TsaR and of AphB (see Figure 1.21, bottom) 
1.5 The activation of LTTRs 
 
The details of the activation mechanism of LTTRs currently remains unknown, although there 
is a consensus that this involves a conformational change upon binding of ligands in the IBC 
located between the RD1 and RD2 subdomains of the LTTR IBD (Momany and Neidle, 2012; 
Pérez-Martín et al., 1994; Schell, 1993). This conformational change is proposed to result in a 
structural rearrangement of the LTTR DBDs bound to the DNA promoter region causing 
relaxation of the DNA bend and allowing transcription to occur (see Figure 1.8) (Fisher and 
Long, 1993; Hryniewicz and Kredich, 1995; van Keulen et al., 1998; Parsek et al., 1995; 
Piñeiro et al., 1997; Toledano et al., 1994; Wang et al., 1992). 
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Figure 1.30: Conformational changes to the DntR IBD upon inducer binding. (A): The crystal structure of apo-
∆N90DntR (grey) overlaid with the crystal structure of ∆N90DntR with one (magenta) and two salicylate 
binding sites occipied (blue). (B): Illustration showing how, when both salicylate binding sites are occupied, the 
conformation of DntR IBD, observed in crystal structures is inconsistent with the formation of the compact 
form homotetramers seen for acetate-/thiocyanate-bound DntR (Smirnova et al., 2004). Figure as published by 
(Devesse et al., 2011). 
 
However, the usefulness of crystal structures to determine the inactive/active states of full 
length LTTRs is complicated by the fact that the IBDs in the crystal structures obtained often 
contain molecules from the crystallisation condition bound in their IBCs. One such example 
is the crystal structure of full-length DntR (Smirnova et al., 2004) in which the IBCs contain 
either acetate or thiocyanate. Comparing the crystal structures of ion-bound full length DntR 
with the structure of the homotetramer of full length CbnR, which was crystallised in the 
absence of any molecules bound in its IBCs (Muraoka et al., 2003) revealed conformational 
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differences, which would cause a conformational change of bound DNA. It was therefore 
argued that the crystal structure of CbnR represented that of an LTTR in an inactive state 
while that of DntR represented an activated LTTR homotetramer. This conclusion was made 
in despite that neither acetate nor thiocyanate caused any measureable fluorescence 
quenching of DntR which would have been indicative of conformational changes as a result 
of acetate or thiocyanate binding (Smirnova et al., 2004). Nevertheless, the hypothesis that 
the activated LTTR homotetramers maintained a compact form was supported by the crystal 
structures of inducer-bound and apo-BenM IBD (Ezezika et al., 2007). However, as the crystal 
structures of the former were produced by soaking crystals of the apo-IBD, room for 
conformational change upon inducer binding was limited by crystal packing. 
Recent crystal structure analyses (Devesse et al., 2011; Monferrer et al., 2010) suggest that 
homotetrameric LTTRs actually undergo a conformational change in which the LTTR changes 
from a compact conformation into a more open form. This is, however, still only a 
hypothesis. While several crystal structures show that full length LTTR homotetramers can 
adopt either compact (i.e. CbnR, (Muraoka et al., 2003); DntR, (Smirnova et al., 2004); BenM, 
(Ruangprasert et al., 2010)) or open conformations (TsaR, (Monferrer et al., 2010); ArgP, 
(Zhou et al., 2010); AphB, (Taylor et al., 2012); PA01 and PA0477 from Pseudomonas 
aeruginosa, (unpublished, PDB codes 3FZV and 2ESN respectively)), to date no LTTR 
homotetramer has been observed to adopt both open and compact states, questioning 
whether or not both conformations are available for a given protein. Moreover, in the single 
case where the crystal structure of a full length LTTR (TsaR; Monferrer et al., 2010)) is 
available in both apo- and inducer-bound forms both homotetramers adopt an open state 
and no conformational change which might result in the relaxation of the bend of bound 
DNA is observed as a result of the inducer binding. 
1.6 Aim of thesis 
 
Given the above it is clear that the elucidation of the activation mechanisms of LTTR 
homotetramers remain elusive and more structural evidence is required. It is also clear that 
the restrictions imposed on the conformation of LTTRs by crystal packing will need to be 
overcome by studying the structures of LTTR proteins in solution. The work described in this 
thesis was directed at shedding more light on the activation mechanism of LTTRs. To this end 
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the LTTR DntR was used as a model system for structural studies employing both X-Ray 
crystallography and Small Angle X-Ray Scattering (SAXS) aimed at elucidating the structures 
of apo- and inducer-bound DntR and that of a point mutant, H169TDntR, which has 
previously been shown to show activity in the absence of an inducer molecule (Lönneborg 
2012). 
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2. Materials and methods 
2.1 Expression and purification 
 
DntR DNA on a pQE-60 plasmid (Figure 2.1) was supplied by Rosa Lönneborg, University of 
Stockholm, Sweden. This expression vector confers ampicillin resistance to the bacteria, 
adds a C-terminal hexa-histidine tag (His6) to the inserted protein sequence and allows for 
protein overexpression upon the addition of isopropyl-β-D-thiogalactopyranoside (IPTG) via 
the T5 promoter/lac operator transcription–translation system. 
 
Figure 2.1: The pQE-60 plasmid. The plasmid contains a beta-lactamase conferring ampicilin resistance and 
expresses a 6x C-terminal Histidine tag via a lac operator system under the control of a T5 promoter. 
2.1.1 Wild type DntR (DntR-His6) 
 
The pQE-60 DntR plasmid was transformed into E. coli strain M15[pREP4] (Qiagen). The 
pREP4 plasmid contained in the genome of these cells constitutively express lac repressor 
causing repression of protein expression prior to IPTG induction and confers kanamycin 
resistance to the bacteria. 100 µl of M15 cells with 1 µl of plasmid DNA were placed on ice 
for 30 minutes, heat-shock transformed at 42oC for 90 seconds then put back on ice for 5 
minutes. 900 µl of Luria Broth (LB) medium were added to the cell suspension which was 
subsequently incubated at 37oC with shaking for 1 hour. The suspension was centrifuged at 
10,000 x g for a few seconds and approximately 950 µl of the supernatant discarded. The 
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pellet was resuspended in the remaining 50 µl which was then plated onto LB Agar plates 
containing 100 µg/ml ampicillin and 50 µg/ml kanamycin. 
After overnight growth at 37oC one colony was selected, added to 100 ml of 100 µg/ml 
ampicilin and 50 µg/ml kanamycin supplemented LB media and grown at 37oC overnight. 
This pre-culture was then used to inoculate 12 l of LB. Cells were grown at 37oC with shaking 
in LB media containing 100 µg/ml ampicilin and 50 µg/ml kanamycin for approximately 3 
hours until an optical density at λ=600 nm (OD600) of 0.6 was reached. Protein expression 
was then induced through the addition of 1 mM (IPTG). To limit degradation, protein 
expression was tested at different conditions: 37oC for 3, 4 or 5 hours; or overnight at 15, 20 
or 25oC. The best ratio of purified protein vs degraded product was obtained for expression 
at 37oC for 5 hours. 
The cells were harvested by centrifugation at 4oC at 5000 x g for 30 minutes. The cell pellet 
was then resuspended in 50 mM Tris hydrochloride, pH 8.0 containing 300 mM NaCl and 5 
mM imidiazole (Buffer A) with the addition of 0.1 mg/ml lysozyme and two pellets of 
c0mplete protease inhibitors (Roche) per liter of culture. The cells were then lysed through 
ultrasound sonication using 10 bursts of 15 seconds each. The resulting solution was 
centrifuged at 20,000 x g for 30 minutes to remove cell debris and the supernatant applied 
to a metal-chelating Hitrap column (GE healthcare Life sciences) previously equilibrated with 
Buffer A. Upon application of the protein to the column this was washed with buffer A 
containing 25 mM imidazole to remove non specifically bound proteins. Initial experiments 
showed that the DntR-His6 obtained was heavily contaminated with DNA. To remove this in 
subsequent experiments, the column was washed with buffer A containing 1 M NaCl prior to 
elution. Elution was then carried out using a gradient of 25 to 500 mM imidazole. Fractions 
from the column (chromatogram depicted in Figure 2.2) containing a single polypeptide of 
~35kDa, as shown by SDS-PAGE analysis (Figure 2.2) were then pooled and dialyzed against 1 
l of a buffer comprising 1M NaCl, 25 mM NaH2PO4-NaOH (pH 8.0) 2 mM MgSO4, 1 mM DTT 
and 17% (v/v) glycerol. The final yield was approximately 1 mg of DntR-His6 per liter of 
culture. The protein was concentrated to 5 mg/ml assuming the theoretical extinction 
coefficient of 18450 M-1 L-1. The concentration was validated by Bradford assays. 
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As shown in Figure 2.2, although it was possible to produce relatively pure DntR-His6 through 
nickel affinity chromatography the main fractions always contained some degraded protein. 
To further purify DntR-His6 from this and other contaminants samples were applied to a gel 
filtration column. 
 
 
Figure 2.2: Purification of DntR-His6 by nickel affinity chromatography. Fractions were analyzed using SDS-
PAGE. The results corresponding to the shoulder and main peaks are shown as inserts. The absorption at λ=280 
nm (A280) is shown in blue and the imidiazole gradient from 0.025-0.5 M is shown in red. 
Gel filtration was performed on an Amersham Biosciences Akta Purifier with a Superdex 200 
column in a running buffer containing 1 M NaCl, 2 mM MgSO4, 1 mM DTT, 5 % (v/v) glycerol, 
25 mM NaH2PO4-NaOH (pH 8.0) at a flow rate of 0.5 ml/min. Fractions of a molecular weight 
of ~150 kDa, corresponding to a DntR-His6 tetramer, were pooled dialyzed against 1 M NaCl, 
2 mM MgSO4, 1 mM DTT, 17% (v/v) glycerol, 25 mM NaH2PO4-NaOH, concentrated by 
centrifugation to 5 mg/ml and ultracentrifuged at 50,000 x g in a optima MAX ultracentrifuge 
to remove remaining aggregated particles. As shown in Figure 2.3 it was never possible to 
fully separate the DntR-His6 from degraded products. Attempts to further purify DntR-His6 
were also made using ion exchange chromatography which resulted in no further 
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improvement (results not shown). As can also be seen in Figure 2.3 DntR exists in 
equilibrium between tetrameric (~150 kDa) and dimeric states (~75 kDa). As the equilibrium 
is clearly heavily shifted towards the tetramer this was not addressed further in studies of 
the tetrameric form of DntR-His6. 
 
 
Figure 2.3: Purification of DntR-His6 by gel filtration. Fractions were analyzed using SDS-PAGE and the results 
corresponding to small and large peaks shown as inserts. A280 is shown in blue, A260 in red.  
In an attempt to eliminate proteolytic cleavage, expression trials were attempted at 
different temperatures and over different periods of time (Table 2.1). These trials did not 
yield significantly different SDS-PAGE expression profiles except for the 3 hour expression at 
37oC which had a very poor protein yield (results not shown). Eventually it was found that 
the addition one c0mplete mini protease inhibitor tablet per liter of culture during cell lysis, 
reducing total sonication time to 1 minute (15 second pulses, 45 second pauses) and, 
particularly, carrying out the purification at 4oC and rigorously keeping the cell lysate on ice 
significantly reduced the amount of degraded protein seen for the full-length constructs 
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(Figure 2.4). Following this procedure, once purified, no further degradation of the full-
length constructs occurred (Figure 2.4). 
Induction temperature (oC) 37 37 37 25 20 15 
Duration of expression (h) 3 4 5 16 16 16 
 
Table 2.1: Combinations of induction temperatures and hours of expression trialled. Cells were grown to an 
OD600 of ~0.3 at 37
o
C after which the temperature was changed. Depending on the temperature expression was 
induced 20-40 minutes later when the OD600 reached 0.6. The various approaches resulted in no difference in 
the ratio between degraded and nondegraded full-length DntR as seen in SDS-PAGE analysis. 
 
Figure 2.4: SDS PAGE analysis of purified DntR-His6. (A): Initial purification trials conducted with low amounts 
of protease inhibitor and at room temperature. The top band has a mass of ~35 kDa, corresponding to the 
molecular weight of the DntR-His6 monomer; several bands corresponding to degraded protein are visible. (B): 
An example of the result using the current purification protocol involving high amounts of protease inhibitor 
and carried out at 4
o
C. (C): Trypsin digests of purified DntR-His6. (D): Purified DntR-His6 left at 4
o
C for 2 weeks 
shows no signs of further degradation. (E): Low molecular weight marker. 
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As expected (Smirnova et al., 2004), DntR elutes on gel filtration as a tetramer. When high 
amounts of DNAse were added to the solution during purification the size exclusion 
chromatography elution profile was shifted from mainly tetramer to mainly dimer (Figure 
2.5). Further experiments are needed in order to verify the relationship between DNA 
presence and quaternary shape. 
 
Figure 2.5: Size exclusion chromatography elution profiles of DntR-His6. A280 shown in blue; A260 in red. The 
peak at 12.5 ml elution volume corresponds to a molecular weight of approximately 150 kDa (tetramer) the 
peak at 16 ml corresponds to 70 kDa (dimer) as determined by calibration measurements (not shown). (A): 
Standard purification procedure of DntR-His6. (B): Purification protocol containing high amounts of DNAse. 
2.1.2 H169TDntR-His6 
 
The H169T mutation was introduced into the wildtype pQE60 DntR construct using forward 
and reverse primers: H169T_F cggcgcctctttcgcacccgctacgtatgcat; H169T_R 
atgcatacgtagcgggtgcgaaagaggcgccg and was amplified by the Polymerase Chain Reaction 
(PCR) using the procedure shown in Table 2.2. 
The PCR products were incubated with 1 µl of the restriction endonuclease enzyme DPN1 
(New England Biolabs) for 2 hours at 37oC to digest the original methylated template. 50 µl 
of competent E. coli strain DH5α with 5 µl of plasmid DNA were then placed on ice for 30 
minutes, heat-shock transformed at 42oC for 90 seconds then put back on ice for 5 minutes. 
900 µl of LB media was added to the cell suspension which was subsequently incubated at 
37oC with shaking for 1 hour. The cell suspension was spun down and approximately 950 µl 
of the supernatant discarded. The pellet was resuspended in the remaining 50 µl which was 
plated onto LB agar plates containing 100 µg/ml of ampicillin. After overnight growth at 37oC 
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one colony was selected added to 10 ml of 100 µg/ml ampicilin supplemented media and 
grown at 37oC overnight. Plasmid DNA was purified through a qiagen miniprep kit and 
yielded approximately 100 ng DNA / µl. Once the H169T mutation had been validated by 
DNA sequencing (www.dna.macrogen.com) 1 μl of plasmid DNA was transformed into 100 μl 
e. coli M15[pREP4]. Expression and purification (Figure 2.6) of H169TDntR-His6 was carried 
out as described for DntR-His6. 
Reaction Mixture PCR Procedure       
50 ng DntR DNA 
    1.25 µl H169T_F (10 µM) Denaturation 30sec 95°C   
1.25 µl H169T_R (10 µM) Denaturation 10sec 95°C 
 2 µl dNTPs (10 mM) Annealing 10sec 68°C X30 
1 µl pfu polymerase Elongation 10sec 72°C   
5 µl pfu buffer 5X Final elongation 5min 72°C 
 27 µl Water 
     
Table 2.2: The PCR procedure used to create H169TDntR. The template DNA, primers, nucleotides and 
polymerase composition of the PCR reaction are shown. Following an initial denaturation step, 30 cycles of 
denaturation, annealing and elongation followed. Finally the product was elongated for an additional 5 
minutes. 
 
Figure 2.6: Purification of H169TDntR-His6 by nickel affinity chromatography. Fractions were analyzed using 
SDS-PAGE (results shown in insert). A280 is shown in blue, the imidiazole gradient from 0.025-0.5 M is shown in 
red. 
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2.1.2.1 Mass spectrometry 
To validate the H169T mutation and to further investigate the composition of degradation 
products obtained during purification a sample purified H169TDntR-His6 was subjected to 
MALDI-TOF mass spectrometry at the facility at the Institut Biologie Structurale, a platform 
of the Grenoble Partnership for Structural Biology (http://www.ibs.fr/platforms/protein-
purification/mass-spectrometry) where samples were analyzed on a 6210 LC-TOF mass 
spectrometer interfaced with LC pump system (Agilent Technologies). The results are shown 
in Figure 2.7A. As illustrated, the H169T mutation was confirmed. The analysis also showed 
that residues at which proteolytic cleavage occurs during protein production are located 
within the linker helix region connecting the C-terminal IBD with the N-terminal wHTH 
domain (Figure 2.7B,C).
 
Figure 2.7: Deconvoluted MALDI-TOF spectrum of H169TDntR-His6. A: full spectrum confirming the H169T 
mutation (molecular weight of 35515 Da, wild type 35551 Da). B: Different species with molecular weights 
around 26 kDa. C: The DntR monomer showing the region of DntR-His6 at which proteolytic cleavage occurs 
during protein production and purification. 
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2.1.3 ∆N90DntR and ∆N90H169TDntR 
 
∆N90DntR-His6 and ∆N90H169TDntR-His6 were produced and purified by a placement 
student (Marie Christou-Kent, University of Bath, UK) under my supervision. As for full-
length DntR, the ∆N90DntR DNA on a pQE-60 plasmid was supplied by Rosa Lönneborg, 
University of Stockholm, Sweden. The H169T mutation was introduced into the ∆N90DntR 
construct using the same primers as for full length H169TDntR and the PCR procedure 
conducted as shown in Table 2.3. Mutations were validated by DNA sequencing 
(www.dna.macrogen.com) 
Mixture PCR       
50 ng DntR DNA 
    1.25 µl H169T_F (10 µM) Denaturation 120sec 95°C   
1.25 µl H169T_R (10 µM) Denaturation 45sec 95°C 
 1 µl dNTPs (10 mM) Annealing 45sec 68°C X30 
1 µl pfu pol Elongation 60sec 72°C   
5 µl pfu buffer 5X Final elongation 60sec 72°C 
 28 µl Water 
     
Table 2.3: The PCR procedure used to create ∆N90H169TDntR. The template DNA, primers, nucleotides and 
polymerase make up the PCR reaction. Following an initial denaturation reaction 30 cycles of denaturation, 
annealing and elongation followed. 
 
Figure 2.8: Purification of ∆N90DntR-His6 by nickel affinity chromatography. Fractions were applied to SDS 
page with the results corresponding to small and large peak shown as inserts. A280 is shown in blue and the 
imidiazole gradient from 0.025-0.5 M is shown in pink. ∆N90H169TDntR-His6 showed an elution profile similar 
to ∆N90DntR-His6 (data not shown). Work of Marie Cristou-Kent (University of Bath, UK). 
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Transformation into E. coli strains DH5α and M15[pREP4] was conducted as previously 
described for full length H169TDntR-His6 (Section 2.1.2). Expression and purification (Figure 
2.8) of ∆N90DntR- His6 and ∆N90H169TDntR-His6 was carried out as previously described for 
∆N90DntR- His6 (Devesse et al., 2011). The protein yield was much larger than for full length 
DntR (~7 mg of protein per liter of culture) and since the DNA binding domain was not 
present in the constructs, there is no issue concerning DNA contamination and with the 
presence of degradation products. 
2.2 pDnT 
 
In order to investigate the DNA binding properties of DntR we wished to create a DNA 
construct (pDnT) containing the sequence of the promoter regions located between the 
DntA and DntR genes, in which the DNA binding sites of DntR should reside. The pDnT 
fragment was constructed with flanking restriction sites for insertion into plasmids to allow 
amplification in DH5α cells. The pDnT fragment was constructed (Figure 2.9) using the four 
primers shown below in PCR reactions. 
primer1  
5'-ATGTCGCGCAGATCCATGACCTCACCCTCACCATTATTCATGCTGGTGATTTTAACTATCAGACTTGATC-3' 
Primer2 
5'-GTTGTCTCCGAATGGCTGCGATTCTAGCGCGTCGATCGGTATAGCGCTATAGATCAAGTCTGATAGTTA-3' 
Primer3 5'-
TCGAAGGTAGGCATATGGGTTGAAGACCACCAGCAGATTCAAGTCGATGTCGCGCAGATCCATGACCT-3' 
primer4 
5'AAGCTTGAATTCGGATCCCTCGAGTTCCATGCAAGCTCTTTTTTCAGTTGTCTCCGAATGGCTGCGATTCT-
3' 
 
PCR reaction 1 was carried out with primer1 and primer2 to create a double stranded DNA 
fragment containing most of the pDnT sequence. Primers3 and 4 were then added in a 
second PCR reaction to add restriction sites. Primers 3 and 4 are complementary only to the 
newly synthesized strands and not primers 1 and 2 and will thus not bind unless the first PCR 
reaction was successful. The full PCR procedure is schematised in Figure 2.9 and details of 
the PCR reactions are given in Table 2.4. 
TCGAAGGTAGGCATATGGGTTGAAGACCACCAGCAGATTCAAGTCGATGTCGCGCAGATCCATG
ACCTCACCCTCACCATTATTCATGCTGGTGATTTTAACTATCAGACTTGATCATATCGCGATATGG
CTAGCTGCGCGATCTTAGCGTCGGTAAGCCTCTGTTGACTTTTTTCTCGAACGTACCTTGAGCTC
CCTAGGCTTAAGTTCGAA 
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Figure: 2.9: The PCR reaction for the creation of the pDnT fragment. Top: sequence of the pDnT fragment, 
restriction sites shown in red. Bottom: PCR1 consists of two complementary primers of about 70 bp with an 
overlap of 18 bp. In PCR2 two additional primers are added which complement the newly synthesised strand 
 
Mixture PCR1       
5 µl Primer1 (2µM) Denaturation 30sec 98°C 
 5 µl Primer2 (2 µM) Denaturation 10sec 98°C   
2 µl dNTPs (10 mM) Annealing 10sec 45°C X29 
0.5 µl (2U) Phusion pol Elongation 10sec 72°C   
10 µl Phusion buffer 5X Final elongation 5min 72°C 
 27 µl Water 
    
     Mixture PCR2       
5 µl PCR1 Denaturation 30sec 98°C 
 5 µl Primer3 (2µM) Denaturation 10sec 98°C   
5 µl Primer4 (2 µM) Annealing 10sec 45°C X29 
2 µl dNTPs (10 mM) Elongation 10sec 72°C   
0.5 µl (2U) Phusion pol Final elongation 5min 72°C 
 10 µl Phusion buffer 5X 
    27 µl Water 
     
Table 2.4: The PCR reactions used to create the pDnT fragment. The product of PCR1 was used as template 
DNA for PCR2. For both reactions an initial denaturation step was followed by 29 cycles of denaturation, 
annealing and elongation and a final elongation step. 
.  
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The products of PCRs1 and 2 were analyzed on 2% agarose gels in Tris-Borate-EDTA (TBE) 
buffer comprising 100 mM Tris, 90 mM boric acid, and 1 mM EDTA and stained with 
CybRSafe (Sigma). As can be seen in Figure 2.10 PCR1, produced a band corresponding to 
approximately 100 bps while PCR2 produced one corresponding to approximately 170 bps. 
The binding between pDnT and DntR-His6 was tested via electrophoretic mobility shift 
assays. Native 5% acrylamide gels were prerun at 30 minutes before load of samples 
comprising DntR in a concentration gradient of 0.16-5 µM. However as shown in Figure 
2.10C, it was not possible to observe a shift of DNA mobility. As the protein concentration 
was increased, DNA would no longer enter the gel. To attempt to overcome this, the gels 
were attempted run either Tris-Borate-EDTA (TBE), Tris pH 8.8 or Tris pH 6.8 with a protein 
buffer sodium chloride gradient from 100-1000 mM. However, in no case did DNA enter the 
gel at protein concentrations higher than 1 µM and thus a shift of DNA mobility was never 
observed. 
 
 
Figure 2.10: PCR reactions and pDnT DntR binding. (A): PCR1. Lanes from left to right: product of PCR1, 
primer1, marker. (B): PCR2: Lanes from left to right: marker, product of PCR reaction 2, primer1. (C): Native 
PAGE of DntR pDnT binding. The lanes show the mobility of the pDnT fragment after having been incubated 
with increasing amounts of DntR. From left to right: marker, the addition of 0, 0.16 µM, 0.8 µM, 1.6 µM, 3 µM 
and 5 µM DntR. 
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2.3 Crystallization 
 
Prior to all crystallization trials the protein solution was centrifuged at 20,000 x g. All trials 
carried out were in hanging drops in which 1 µl of the protein stock solution (~5mg/ml) and 
1 µl of a reservoir solution were equilibrated against 500 µl of the reservoir solution. Crystals 
obtained and used for diffraction data collection were cryoprotected in solutions comprising 
the relevant reservoir solution supplemented with 20% glycerol then flash frozen in liquid 
nitrogen. 
2.3.1 DntR-His6 
 
Crystals of DntR-His6 were grown at 18
oC. Crystals of thiocyanate-bound DntR-His6 were 
obtained as previously reported by (Smirnova et al., 2004). Crystals of the apo-form of DntR-
His6 were obtained using a reservoir solution comprising 0.2 M sodium potassium tartrate, 
0.1 M tris (pH 8.0) 5 % (w/v) PEG 6000.  
2.3.2 H169TDntR-His6 
 
Crystals of H169TDntR-His6 were obtained in both of the conditions described above for 
DntR-His6. However, the crystallization conditions containing no thiocyante produced 
crystals diffracting only to dmin ~ 12 Å. Despite several attempts at optimization this 
diffraction limit could not be improved and the crystal structure of H169TDntR-His6 was 
therefore obtained from crystals grown in the presence of thiocyanate. 
2.3.3 Salicylate-bound DntR-His6 
 
To attempt to grow crystals of full length DntR-His6 bound to salicylate, the protein was 
incubated with 20, 200 or 5000 µM sodium salicylate prior to the setting up of crystallization 
drops using a reservoir consisting of 0.2 M sodium potassium tartrate, 0.1 M tris (pH 8.0), 5 
% (w/v) PEG 6000. The crystals obtained following preincubation with 200 µM sodium 
salicylate are shown in Figure 2.11. No crystal growth was observed in wells containing 5 
mM sodium salicylate. Initial tests showed that one of the crystals shown in Figure 2.11 
diffracted to dmin = 2.15 Å, the highest resolution obtained thus far for crystals of full length 
DntR. Full diffraction data collection, structure solution and refinement were carried 
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therefore carried out (Table 2.5). At the end of the refinement procedure the electron 
density for the IBC of molecule A in the asymmetric unit appeared to be consistent with a 
mixture of two different conformations of the IBC (not shown). The diffraction data were 
therefore analysed further and it was found that, although this had not been observed for 
other crystal structures of DntR for which data are reported here, the Cumulative Intensity 
Distribution indicates partial merohedral twinning (Figure 2.12). A consequence of this is 
that the crystal symmetry is lower than the 622 imposed and that the asymmetric unit 
contains four rather than two molecules. However, refinement in a lower symmetry 
spacegroup did not improve the solution (i.e. the electron density in the vicinity of the IBC 
was still disordered). Moreover, refinement in either p6522 or p65 spacegroups did not 
indicate that salicylate was bound in the IBC. This crystal structure will thus not be discussed 
further. 
 
 
Figure 2.11: Crystals of full-length DntR grown in the presence of salicylate. DntR was pre-incubated with 200 
µM sodium salicylate. Crystallisation drops comprised 1 l pre-incubated DntR and 1 l of a precipitant solution 
containing 200 µM sodium salicylate (see main text). 
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Dataset DntR in presence of Salicylate 
Beam-line 
Wavelength  
ID23-1 (ESRF) 
0.976 
Space group P 6522 
Unit cell dimensions:  
   a,b,c (Å) 107.65 107.65 292.48 
   α,β,γ (°) 90.00  90.00 120.00 
Resolution range (Å) 47.16 – 2.15 
Number of unique reflections 55226 
Multiplicity 4.5 (4.6) 
Completeness (%) 99.7 (100) 
Rmerge  0.088 (0.905) 
<I/σ(I)>  10.3 (2.1) 
Wilson B factor Å2 47.300 
  
Model quality indicators  
R-factor (%) 22.06 
Free R-factor (%) 24.86 
RMS deviations:  
   Bonds (Å) 0.020 
   Angles (°)  1.375 
 
Ramachandran analysis (%)  
Favored regions 96.86 
generously allowed regions 2.42 
Disallowed regions 0.72 
 
Table 2.5: Data collection and refinement statistics for crystals of DntR-His6 grown in the presence of 
salicylate. Figures in parentheses are for the highest resolution range for the data set (2.27-2.15 Å). 
 
 
Figure 2.12: Cumulative Intensity Distribution plots for crystals of apo-DntR-His6 and DntR-His6 grown in the 
presence of salicylate. apo-DntR-His6 (left) and DntR-His6 pre-incubated with 200 µM sodium salicylate (right). 
Theoretical values for centric and acentric reflections (black and red) are shown along with observed values 
(magenta and green respectively). Theoretical values for a perfectly merohedrally twinned dataset are shown 
in blue. 
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2.3.3.1 High throughput crystallization trials 
 
In a further attempt to obtain crystals of salicylate-bound DntR-His6 a stock solution 
consisting of 5 mg/ml DntR-His6 in 1 M NaCl, 2 mM MgSO4, 1 mM DTT, 17% (v/v) glycerol, 25 
mM NaH2PO4-NaOH, 200 µM sodium salicylate was sent for high throughput screening trials 
at the EMBL Grenoble High Throughput Crystallization (HTX) lab (https://embl.fr/htxlab). In 
total 576 conditions were screened. After three days crystal-like conformations could be 
observed in four conditions (Figure 2.13). Attempts to reproduce these in 2 µl hanging drops 
were unsuccessful. 
 
Figure 2.13: Crystals of potential salicylate-bound DntR-His6 obtained from high throughput crystallization 
screening. The reservoir conditions were as follows: A: 0.2 M Li2SO4(H2O), 0.1 M Tris-HCL pH 8.5, 15% PEG 
4000. B: 0.2 M sodium citrate, 20% PEG3350. C: 0.01M ZnSO4, 0.1M MES pH 6.5, 25% PEG 550 MME. D: 0.2 M 
NaCl, 0.1 M tris pH 8.5, 25% PEG 3350. 
2.3.4 Crystal data collection and refinement 
 
Diffraction data from a single crystal of apo-DntR-His6 were measured on beam-line ID29 (de 
Sanctis et al., 2012) of the ESRF. Diffraction data from crystals of H169TDntR-His6 were 
recorded at ID23-1 (Nurizzo et al., 2006). In both cases, diffraction images were processed 
using XDS (Kabsch, 2010), intensities merged using the program SCALA (Evans, 2011) and 
structure factors derived using TRUNCATE (French and Wilson, 1978). 
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For all crystals analyzed systematic absences in the data sets indicated the space group to be 
either P6122 or P6522. Structure solution was performed using Molecular Replacement (MR) 
in the program PHASER (McCoy et al., 2007) using a monomer from the PDB deposition 
1UTB (thiocyanate-bound DntR, Smirnova et al., 2004), stripped of solvent and thiocyanate 
molecules, as a search model. In both cases the MR protocol confirmed the space group to 
be P6522. For apo-DntR structure refinement was carried out in REFMAC5 (Murshudov et al., 
2011) interspersed with rounds of manual rebuilding in WinCoot (Emsley et al., 2010). 
Structure refinement of H169TDntR-His6 was carried out in Phenix (Adams et al., 2010) again 
intersperced with rounds of manual rebuilding in wincoot. All programs used except XDS and 
Phenix are distributed via the CCP4 package (Winn et al., 2011). The X-ray data collection, 
analysis and refinement procedure used throughout this thesis is summarized in Figure 2.14. 
Crystal characterization and data collection strategies were calculated using EDNA 
(Incardona et al., 2009) and BEST (Bourenkov and Popov, 2010). 
 
 
Figure 2.14: The crystallographic data collection, analysis and refinement strategy used. Dark blue boxes 
indicate programs utilized. 
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2.3.5 Thermofluor assays 
 
To assess the thermal stability, thermofluor assays were carried out by the EMBL high 
throughtput crystallisation (HTX) platform (https://embl.fr/htxlab). Stock solutions (see 
section 2.3.3.1 for compositions) containing 5 mg/ml apo-DntR, apo-H169TDntR and DntR 
preincubated with 100 µM sodium salicylate were sent to the platform for such assays. 
2.4 Small Angle X-ray Scattering (SAXS) 
 
All measurements from solutions containing various DntR-His6 constructs were collected 
using a Pilatus 1M detector (Dectris Ltd., Baden, Switzerland) in the momentum transfer 
range 0.04 < q < 0.61 Å-1 (q = 4π sin θ/λ, 2θ is the scattering angle between the incident and 
scattering beam). For static measurements, prior to data collection solutions were 
centrifuged at 16,000 x g for 10 minutes before being transferred to an automatic liquid 
handler (Pernot et al., 2013) in which they were stored at 4oC prior to measurements. All 
measurements of SAXS scattering curves were then conducted at 4oC. Invariant parameters, 
Rg, I(0), Dmax were deduced from the scattering curves as outlined in Section 2.4.3. 
2.4.1.1 ∆N90DntR-His6 and ∆N90H169TDntR-His6 
 
Scattering curves from solutions of ∆N90DntR-His6 and ∆N90H169TDntR-His6 were 
measured at the ESRF beamline bioSAXS BM29 (Pernot et al., 2013) at λ=0.992 Å at 
concentrations of 5 and 3 and 1 mg/ml. Samples were flowed through the beam to avoid 
radiation damage and 10 x 10 frames were recorded for each sample. 
Unsurprisingly, the scattering curves of both constructs are very similar (Figure 2.15), an 
impression confirmed by analysis of the invariant parameters (Table 2.6). A pair-distribution 
function , P(r), was determined from the scattering curve of ∆N90DntR-His6 and a bead 
model of its solution structure created as outlined in Section 2.4.3. This confirms both 
∆N90DntR-His6 and ∆N90H169TDntR-His6 to be dimers in solution. 
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Figure 2.15.: Scattering curves for ∆N90DntR-His6 and ∆N90H169TDntR-His6. Scattering curves displaying log(I) 
as a function of q for solutions of ∆N90DntR-His6 (black) and ∆N90H169TDntR His6 (red) after buffer 
subtraction. 
 
To produce holo-ΔN90DntR, ΔN90DntR-His6 was pre-incubated with 5 mM sodium salicylate. 
However, this did not induce any significant changes in the scattering curve measured 
(Figure 2.16). Taken together, Figures 2.15, 2.16, 2.17 and Table 2.6 shows that there is no 
SAXS measureable conformational change in the structure of the ∆N90DntR-His6 dimer upon 
inducer binding. Any studies using SAXS that aim to help in the elucidation of the 
active/inactive forms of DntR should thus focus on the full-length protein. 
 
Figure 2.16: Scattering curves from solutions of ∆N90 DntR-His6 construct in the absence and presence of 5 
mM salicylate. Scattering curve displaying log(I) as a function of q for solutions of apo-N90DntR-His6 (green) 
and N90DntR- His6 in the presence of 5 mM salicylate (blue). In both cases the curves displayed are those 
obtained after buffer subtraction 
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Invariant parameters apo-ΔN90DntR apo-ΔN90H169TDntR holo-ΔN90DntR 
Dmax (Å) 65 63 64 
Rg (Å) 25.12 +/- 0.43 25.32 +/- 0.33 25.08 +/- 0.38 
Table 2.6: Invariant parameters obtained from the scattering curves of ΔN90DntR constructs. 
 
Figure 2.17: ab initio model of the solution structures of ∆N90DntR-His6. The ab initio envelope (grey mesh) 
overlaid with the crystal structures of the apo-∆N90DntR dimer (left) and holo-∆N90DntR dimer (right) 
(Devesse et al., 2011). 
2.4.1.2 DntR-His6 
 
Scattering curves from solutions of apo-DntR-His6 were measured on the ESRF bioSAXS 
beamline ID14-3 (Zerrad et al., 2011) at λ=0.931Å. 10 frames each of 10 seconds exposure 
time were recorded for each measurement. Repeated exposure induced no difference in the 
SAXS scattering curves suggesting that radiation damage had not occurred. Scattering curves 
from DntR-His6 in its apo- state were measured at concentrations 3, 1 and 0.5 mg/ml. To 
produce DntR-His6 in its holo-state solutions containing 1 mg/ml DntR were incubated with 
5, 20, 100 or 5000 µM sodium salicylate for 10 minutes prior to measurements. For each 
sample 10 x 10 frames were collected. Sodium salicylate at high concentrations induced 
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interparticle interactions. For this reason such measurements conducted at a DntR-His6 
concentration of 3 mg/ml, although carried out, had to be discarded. 
2.4.1.3 H169TDntR-His6  
 
Scattering curves from solutions of apo-H169TDntR-His6 were measured at the ESRF 
beamline BM29 at λ=0.992 Å at a concentration of 0.7 mg/ml. In order to achieve higher 
resolution data 10 x 10 frames each of 2 seconds exposure time were recorded and 
averaged. Samples were flowed through the beam to reduce radiation damage.  
 
2.4.2 HPLC-coupled SAXS experiments 
 
Measurements of the scattering curves of solutions of DntR constructs that were subject to 
gel-filtration immediately prior to exposure to X-rays were also recorded at the ESRF 
beamline BM29. The beamline setup, shown in Figure 2.18, makes it possible to load 
samples on to different kinds of HPLC columns, in this case a gel filtration SD200 column, and 
to inject the eluent directly into the X-ray beam. This allows for a quasi-instantaneous 
measurement of the scattering curves of species that would otherwise be impossible to 
separate due to fast exchanging equilibria. It also makes it possible to separate any 
aggregated particles. As the flowthrough from the column is exposed constantly by X-rays, 
effective exposure time and solution concentration is lower than those when performing 
static measurements. This causes individual measurements of scattering curves to be noisier 
than for static measurements. However, as the sample will usually elute across ~1-2 minutes 
the averaging of many individual measurements of scattering curves allows for the higher 
resolution data than might otherwise be expected. 
In this work gel-filtration-coupled SAXS measurements were carried out for solutions of both 
apo-DntR-His6 and holo-DntR-His6. In both cases data were collected at λ=0.992 Å and 3500 
frames of each 1 second exposure time were recorded as the eluent flowed through the 
sample cell. Gel filtration of was performed on a Viscotek GPCmax with a Superdex 200 
column. 400 µl protein solution at approximately 5 mg/ml was loaded on the column. To 
obtain data for holo-DntR-His6, prior to application solutions were incubated with 5 mM 
sodium salicylate for 30 minutes. In the absence of sodium salicylate the column was run in a 
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buffer containing 1 M NaCl, 2 mM MgSO4, 1 mM DTT, 5 % (v/v) glycerol, 25 mM NaH2PO4-
NaOH (pH 8.0) at a flow rate of 0.5 ml/min. For holo-DntR-His6 100 µM sodium salicylate was 
added to the elution buffer. A summary of the results of invariant parameters obtained (Rg, 
Dmax and I(0)) of the two experiments are shown in Figure 2.19 (apo-DntR-His6) and 2.20 
(holo-DntR-His6) respectively. As can be seen, in both cases the values of the invariant 
parameters obtained automatically from the individual scattering curves changes markedly 
in the last quarter of the frame range presented. These clearly do not contain the same 
species as the first 75% of the frames and were thus eliminated from subsequent manual 
processing. 
 
 
 
Figure 2.18: The setup for HPLC-coupled BioSAXS at ESRF beamline BM29. Top: The experimental hutch of 
beamline BM29 at the ESRF. The sample environment contains an HPLC setup (lower right corner) that allows 
for chromatography columns to be mounted. Bottom: schematized diagram of the experimental setup. The 
eluent from the column runs directly into the sample cell allowing for almost instantaneous measurements of 
scattering curves. Bottom Figure adapted from 
http://www.esrf.eu/UsersAndScience/Experiments/MX/About_our_beamlines/BM29). 
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Figure 2.19: Summarized output file for HPLC-coupled SAXS experiments of solutions of apo-DntR-His6. The 
top panel shows the total scattering for each frame. The remaining panels shows parameters (Rg, I(0) Dmax) and 
porod volume obtained by automated Guinier fits and GNOM plots. The green line corresponds to the quality 
estimate calculated by AUTOGNOM. Only frames where similar values of Rg and I(0) indicated a single species 
(1715-1809) were used in subsequent processing as indicated by dotted black lines. 
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Figure 2.20: Summarized output file for HPLC-coupled SAXS experiments of solutions of holo-DntR-His6. The 
top panel shows the total scattering for each frame. The remaining panels shows parameters (Rg, I(0) Dmax) and 
Porod volume obtained by automated Guinier fits and GNOM plots. The green line corresponds to the quality 
estimate calculated by AUTOGNOM. Only frames where similar values Rg and I(0) indicated a single species 
(1626-1688) were used in subsequent processing as indicated by dotted black lines. 
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2.4.3 SAXS Data analysis 
 
A flowchart showing the protocol used for SAXS data analysis and processing is shown in 
Figure 2.21. Data analysis for all SAXS measurements was performed in ATSAS 2.4.2 and 
2.4.3 available from the EMBL Hamburg group (http://www.embl-
hamburg.de/bioSAXS/software.html). Radii of gyration (Rg) were determined from Guinier 
plots using PRIMUS (Konarev et al., 2003). In cases where Guinier regions where chosen 
manually, ranges were chosen within the valid range (in which 0.8 > q*Rg > 1.2). Pair 
distribution functions, P(r), and the resulting Dmax values were estimated using the indirect 
Fourier transformation program GNOM (Konarev et al., 2003). Theoretical scattering based 
on the crystal structures of full-length DntR (Smirnova et al., 2004) and TsaR (Monferrer et 
al., 2010) were generated and fitted against measured scattering curves using the program 
CRYSOL (Svergun et al., 1995). Auto processing of frames recorded after HPLC was 
conducted using EDNA for BioSAXS (Kieffer et al, unpublished). 
For purposes of comparison a homology model, constructed using Swiss-Model (Schwede et 
al., 2003), of a hypothetical DntR homotetramer adopting the same open form as seen in the 
crystal structure of TsaR (Monferrer et al., 2010) (Figure 1.21) was created. 
2.4.3.1 Ab initio modelling 
 
Ab initio models of the solution structures of apo-DntR-His6, holo-DntR-His6 and apo-
H169TDntR-His6 were generated by the same method. Based on generated P(r) functions as 
input files, twenty independent bead models, using different randomized seeds, were 
generated using simulated annealing in the program DAMMIF (Franke and Svergun, 2009). 
The resulting models were aligned, averaged and filtered using the program package 
DAMAVER (Volkov and Svergun, 2003). Models were generated both without any symmetry 
restraints (apo-DntR-His6 and ΔN90DntR-His6) and with imposed P22 symmetry (apo-DntR-
His6, holo-DntR-His6 and apo-H169TDntR-His6). 
2.4.3.2 Rigid body modelling 
 
In order to obtain improved models, independent of bias introduced through the modelling 
of P(r) functions, of the solution structures of apo-DntR-His6 and holo-DntR-His6, rigid body 
refinement based on the crystal structure of acetate-bound DntR (Smirnova et al., 2004) was 
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carried out. Here, dimeric C-terminal units (residues 86-301) and the four N-terminals 
domains (residues 1-85) were treated as rigid bodies and their positions refined against the 
experimental scattering curves using SASREF (Petoukhov and Svergun, 2005) with 
connectivity restraints of 3Å between residue 85 and 86 for each monomer. The SASREF 
procedure is shown in Figure 2.22. 
 
 
 
Figure 2.21: Flowchart of SAXS data processing. Programs utilized are shown in black boxes. The 
determination of Guinier regions is required for any data analysis. It indicates which low angle data points to 
truncate and is a quality indicator for the dataset. If a Guinier region cannot be determined the data is most 
likely aggregated or not of sufficient quality for further analysis. The Guinier region determination also provides 
the invariant parameters Rg and I(0) providing information about the size and oligomerisation (i.e.. monomer, 
dimer, tetramer etc) of the molecule in solution. 
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Figure 2.22: Rigid body modelling of the solution structures of apo- and holo-DntR-His6. The domain structure 
of the (Smirnova et al., 2004) model of the structure of a DntR homotetramer is divided into several rigid 
bodies. The theoretical scattering intensities of each of the rigid bodies are then calculated in CRYSOL. These 
are then used as input for SASREF along with connectivity restraints ensuring that the main polypeptide chain 
remains connected. SASREF then refines the position of the rigid bodies within the given restraints against the 
experimental scattering curve and generates a model of the solution structure. 
2.5 Figure preparation 
 
All images of crystal structures, SASREF generated rigid body models and ab inito envelopes 
were produced using the molecular program PyMOL (www.PyMOL.org) developed by 
DeLano, WL 2002. Coordinates for previously solved crystal structures were downloaded 
from the Protein Data Bank (www.rscb.org). Electron density maps were exported into a 
PyMOL readable format using the program FFT from the CCP4 package. 
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3 Results 
 
Although a C-terminal His6 tag was present in all DntR constructs expressed, purified and 
studied in this thesis work, for simplicity, the –His6 will be omitted from the construct names 
in the following Sections (i.e. DntR not DntR-His6 etc). 
3.1 apo-DntR 
3.1.1 The crystal structure of apo-DntR 
 
Based on differences observed between the crystal structure of CbnR (Muraoka et al., 2003) 
and the model they obtained for the full-length structure of acetate-/thiocyanate-bound 
DntR, Smirnova and colleagues suggested that the structure they had obtained was that of 
activated DntR (Smirnova et al., 2004). However as outlined in Section 1.5 the suggestion 
was made despite the lack of any measureable fluorescence quenching of DntR upon acetate 
or thiocyanate binding. 
In the work presented here, crystals of apo-DntR were obtained using the crystallization 
conditions described in Section 2.3.1 and its crystal structure solved and refined (Table 3.1). 
This represents the first crystal structure of apo-DntR. Moreover, as can be seen in Figure 3.1 
during the refinement of the crystal structure it was also possible, although they are still 
clearly very mobile, to model the linker/HTH domains of the homotetramer to a much larger 
extent than had been possible in the work described by (Smirnova et al., 2004) and in 
subsequent crystal structure of DntR point mutants (Lönneborg et al., 2007). The result 
presented here (Figure 3.2) thus also represents the first complete crystal structure of a full-
length DntR. 
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Figure 3.1: Electron density for the N-terminal regions in the crystal structure of apo-DntR. 2mFo-DFc electron 
density (mesh), at the end of the refinement procedure for a HTH/linker helix region of a apo-DntR monomer 
contoured at 1.0 σ (top) and 0.5 σ (bottom). The resulting model of this region is shown in stick representation 
with carbon atoms shown in green, nitrogen atoms in blue and oxygen atoms in red. 
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Figure 3.2: The crystal structure of apo-DntR. Top: The DntR head-to-tail dimer observed in the asymmetric 
unit for of the apo-DntR crystals. Bottom: The crystal structure of the full length apo-DntR homotetramer 
constructed based on symmetry related head-to-tail dimers such that they have coordinates (x, y, z) and (1-x, y, 
½-z). 
 
81 
 
Dataset apo-DntR 
Beam-line 
Wavelength (Å) 
ID29 (ESRF) 
0.976 
Space group P 6522 
Unit cell dimensions:  
   a,b,c (Å) 107.13 107.13 297.84 
   α,β,γ (°) 90.00  90.00 120.00 
Resolution range (Å) 47.14 - 2.64 
Number of unique reflections 30064 
Multiplicity 7.9 (8.2) 
Completeness (%) 99.7 (98.1) 
Rmerge  0.102 (1.047) 
<I/σ(I)>  13.5 (2.1) 
Wilson B factor (Å2) 
 
77.547 
Refined model composition  
Molecule A 
Molecule B 
Glycerol molecules 
Water molecules 
 
M1-K29, T31-L52, E61-H303 
D5-52, E61-E300 
9 
83 
 
 
Model quality indicators 
 
R-factor (%) 19.89 
Free R-factor (%) 22.68 
RMS deviations:  
   Bonds (Å) 0.007 
   Angles (°)  0.972 
 
 
B factors (Å2) 
 
<B>  93.8 
<B> IBD atoms only 70.6 
<B> water molecules 61.7 
  
Ramachandran analysis (%)  
Favored regions 95.2 
Generously allowed regions 4.2 
Disallowed regions 0.5 
 
Table 3.1: Data collection and refinement statistics for the crystal structure of apo-DntR. The numbers in 
parentheses are for the highest resolution range for the data set (2.79-2.64 Å).    
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As can be seen in Table 3.1 the crystals of apo-DntR obtained appear isomorphous to those 
obtained for DntR in complex with either acetate or thiocyanate (Smirnova et al., 2004). This 
is reflected in the crystal structure obtained (Figure 3.2) which, globally, is very similar to 
that observed for acetate-/thiocyanate-bound DntR. As for the crystal structures of acetate-
/thiocyanate-bound DntR the asymmetric unit of the crystal structure of apo-DntR contains a 
head-to-tail dimer with a compact DntR homotetramer being constructed by the association 
of two symmetry related dimers. Moreover, a superposition of the model of thiocyanate-
bound DntR obtained by (Smirnova et al., 2004) and the apo-DntR crystal structure 
elucidated here shows a r.m.s. deviation in C positions of 1.04 Å. 1190 residues aligned 
(Figure 3.3, Bottom) and a r.m.s. deviation of 0.6 Å for the superposition of atoms in the IBD 
tetrameric core only. Indeed, the only significant difference between the structure reported 
here and those obtained by (Smirnova et al., 2004) is that the DntR Inducer Binding Cavity 
(IBC) is devoid ions and contains only ordered water molecules (Figure 3.4). This confirms 
the truly apo-nature of the structure described here. As can be seen from Figure 3.3, when 
comparing the structures of apo- and acetate-/thiocyanate-bound DntR homotetramers 
there are slight differences in the positions of the wHTH dimers flanking the cores of the IBD 
tetramers, however, as the electron density was not sufficient to fully model these domains 
in the crystal structures of thiocyanate- or acetate-bound DntR, it is uncertain whether this 
difference is an artefact. 
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s 
Figure 3.3: A superposition of the crystal structures of homotetrameric apo-DntR and thiocyanate-bound 
DntR. Top: Orthogonal views of a superposition of the full length tetramers. The monomers of apo-DntR are 
shown in different colors and thiocyanate-bound DntR in black. The r.m.s deviation in C positions is 1.04 Å. 
Bottom: A superposition of the IBD tetrameric cores, the monomers of apo-DntR are shown in green and 
yellow, those of thiocyanate-bound DntR in black. 
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That the crystal structure of apo-DntR and acetate-/thiocyanate-bound DntR are so similar 
suggests that, in contrast to what had previously been proposed (Smirnova et al., 2004), the 
crystal structures of acetate and thiocyanate-bound DntR do not represent DntR 
homotetramers in an active conformation but rather in an inactive conformation. This idea is 
further validated by a comparison of the conformation of the IBCs observed in apo-, 
thiocyanate- and acetate-bound crystal structures (Figure 3.5). These are virtually identical. 
It could even appear that the acetate and thiocynate ions are reinforcing the apo state of the 
IBC by forming direct or solvent mediated hydrogen bonds with amino acid residues H169 
and H206 which are required for salicylate binding (Devesse et al., 2011). Figure 3.6 shows a 
comparison of the conformation of the IBCs observed in the crystal structures of apo-DntR 
and holo-ΔN90-DntR (Devesse et al., 2011). This makes it clear that with residues H169 and 
H206 locked in position by either acetate of thiocyanate DntR cannot bind salicylate as this 
requires an enlarged IBC formed by the displacement of the residues, particulary H169, that 
make up the IBC.  
 
Figure 3.4: Electron density for the IBC in the crystal structure of apo-DntR. 2mFo-DFc electron density, at the 
end of the refinement procedure, in the region of the IBC in the crystal structure of apo-DntR contoured at the 
0.9 x r.m.s level.  
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Figure 3.5: A superposition of IBCs of the crystal structures of tetrameric apo-DntR and of acetate-
/thiocyanate-bound DntR. Top: Superposition of the IBCs seen in the crystal structures of apo-DntR (grey 
carbon atoms) and thiocyanate-bound DntR (orange carbon atoms). Bottom: Superposition of the IBCs of apo-
DntR (grey carbon atoms) and acetate-bound DntR (green carbon atoms).  
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Figure 3.6: Comparison of the conformations of the IBCs of apo-DntR and holo-ΔN90-DntR. A superposition of 
the IBCs seen in the crystal structure of apo-DntR (grey carbon atoms), and salicylate-bound ΔN90-DntR (yellow 
carbon atoms) (PDB 2Y7W). The Figure shows that a displacement of residues H169, H206 and R248 is required 
for salicylate binding. 
3.1.2 Small Angle X-ray Scattering analysis apo-DntR 
 
Although the crystal structure of apo-DntR appears to provide unequivocal evidence that 
apo-DntR homotetramers adopt a compact tetrameric structure, crystal packing effects 
might produce artefacts (Dickerson et al., 1994), that do not allow apo-DntR to adopt its in-
solution conformation. To examine the behaviour of apo-DntR in solution SAXS experiments 
were performed. As outlined in Materials and Methods, DntR has a tendency to form higher 
order multimers. This complication made SAXS measurements at high concentrations of 
DntR unfeasible. Nevertheless, it was possible to obtain a satisfactory scattering curve 
containing no interparticle effects, combining measurements from solutions with apo-DntR 
concentrations of 3, 1 and 0.5 mg /ml (Figure 3.7). In the SAXS experiments a minimum of 
17% (v/v) glycerol was added to the protein buffer to prevent inter-particle effects. Glycerol 
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reduces the contrast in electron density between the sample and solvent resulting in lower 
intensity which, in turn, reduces the apparent I(0) value. This makes molecular weights 
determined using I(0) unreliable (Putnam et al., 2007). This value is thus not used in any 
conclusions made concerning the solution structure of apo-DntR. 
Analysis of the Guinier region of the scattering curve yielded a Rg value of 38.8 Å. The pair 
distribution function (P(r)) derived from the scattering curve (Figure 3.8) indicates a 
maximum intra molecular distance of 118.2 Å, which is significantly shorter than the 
maximum distance (130 Å) observed in the crystal structure of full length apo-DntR 
homotetramers (Figure 3.8). CRYSOL fits (Figure 3.9) of the experimental scattering curve 
and theoretical scattering curves calculated from the crystal structure of apo-DntR and the 
open form DntR homology model based on the crystal structure of TsaR (Section 3.4.3) did 
not provide good fits and suggested that the solution structure of apo-DntR is significantly 
different to that observed in the crystal structures of both DntR and in the homology model 
of open-form DntR. 
 
Figure 3.7: The solution scattering curve and corresponding Guinier region for apo-DntR. Solution scattering 
curve displaying log(I) as a function of q. The curve displayed is the result of merging scattering curves 
measured at concentrations of 3, 1, and 0.5 mg/ml. Insert: Guinier region data points (black) and the resulting 
fit (red) derived from AUTOGNOM which yielded Rg= 38.8 Å. 
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Figure 3.8: The P(r) function of the solution structure of apo-DntR. Left: SAXS-derived P(r) function obtained 
from the scattering curve shown in Figure 3.7 by indirect Fourier transformation using the program GNOM. 
Right: The crystal structure of the apo-DntR homotetramer with the longest intra molecular distance, as 
measured in PyMOL, displayed. 
3.1.2.1 ab initio modelling 
 
ab initio molecular envelopes of the solution structure of apo-DntR were created in DAMMIF 
(Franke and Svergun, 2009) based on the P(r) function shown in Figure 3.8. Models were 
created both without symmetry restraints and with P22 symmetry imposed. In both cases 20 
independent models were obtained and averaged with DAMAVER. The results are shown in 
Figure 3.10. As expected from the P(r) function, the envelopes obtained indicate that the 
solution structure of apo-DntR is less elongated than that seen in the crystal structure 
described in Section 3.1.1.  
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Figure 3.9: SAXS analysis of apo-DntR - CRYSOL fits of experimental and theoretical scattering curves. To 
avoid any interference from interparticle effects the first few data points were removed. Top: CRYSOL fit of the 
experimental scattering curve obtained for apo-DntR and a theoretical curve based on the crystal structure of 
apo-DntR described in Section 3.1.1. Bottom: CRYSOL fit of the experimental scattering curve obtained for apo-
DntR and a theoretical curve based on a homology model of open apo-DntR (see Section 2.4.3). 
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Figure 3.10: SAXS-derived ab initio molecular envelopes for the solution structure of the apo-DntR 
homotetramer overlaid with the crystal structure of the apo-DntR homotetramer. Models were based on 20 
independent DAMMIF runs averaged and filtered with DAMAVER. The filtered models are shown. Enveloped 
were generated with imposed P22 symmetry (grey mesh, top) and without symmetry restrictions (brown mesh, 
bottom). The crystal structure of apo-DntR was manually superposed in PyMOL. 
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3.1.2.2 Rigid body modelling 
 
In order to obtain a model of the solution structure of apo-DntR independent of bias 
introduced through the modelling of P(r) functions, rigid body refinement using SASREF was 
employed. The refinement protocol was based on the crystal structure of the apo-DntR 
described earlier (Section 3.1.1). Rigid bodies (Figure 3.11) were defined as described in 
Section 2.4.3.2. Each of the two IBD dimers (green and yellow in Figure 3.11) making up the 
compact DntR tetrameric core were treated as single rigid bodies; the 4 N-terminal wHTH 
domains were also each treated as individual rigid bodies. The division of the N and C 
terminal domains was set between residues T85 and T86 and a connectivity restraint of 3Å 
was used to ensure that the two domains in each monomer remained connected. To ensure 
that the two wHTH domains making up a single dimeric DBD remained close together in 
space a connectivity restraint of 10 Å between residues A75 in the two monomers making up 
the dimer was employed.  
The result of the SASREF procedure is shown in Figure 3.12 and Table 3.2. As can be seen, 
the resulting model provides a much better fit to the ab initio envelope obtained (Figure 
3.13) and, as expected from values of Dmax is less elongated in solution than apo-DntR 
homotetramer as seen in its crystal structure (Figure 3.14). In particular the wHTH dimers 
flanking the tetrameric core are packed closer to this than in the crystal structure. As 
previously demonstrated by the disordered electron density for these domains in crystal 
structures of homotetrameric DntR (Smirnova et al., 2004; this work) they are flexible and it 
therefore seems likely that their positions in crystal structures are a result of crystal packing 
trapping them in a state which is not their preferred in-solution position. 
 
Model χ2 
SASREF generated solution structure 1.010 
apo-DntR Crystal structure 2.114 
Open-form homology model 1.870 
 
Table 3.2: χ2 values of the CRYSOL fits shown in Figure 3.9 and 3.12. 
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Figure 3.11: The rigid body composition of the crystal structure of DntR used in SASREF. The six rigid bodies 
used are shown in different colors. 
 
Figure 3.12: Calculated scattering of the SASREF generated solution structure of apo-DntR vs. the 
experimental data. The theoretical scattering curve of the model generated (red) fitted against the 
experimental data (black). 
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Figure 3.13: SASREF-derived solution structure and ab initio envelopes for homotetrameric apo-DntR. Three 
orthogonal views of the solution structure of homotetrameric apo-DntR as generated by SASREF overlaid with 
ab initio envelopes generated by DAMMIF and DAMAVER. The ab initio models are those created with imposed 
p22 symmetry.  
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Figure 3.14: Orthogonal views of solution and crystal structures of apo-DntR. Top: Orthogonal views of the 
solution structure of the apo-DntR homotetramers generated by SASREF. Bottom: Orthogonal views of the 
Crystal structure of full length apo-DntR. The major difference between the two is a clear change in the 
position of the wHTH dimers flanking the central IBD core. 
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3.2 H169TDntR 
 
It has previously been shown that the H169T mutation causes DntR to be active even in the 
absence of an inducer molecule (Lónneborg, 2011, PhD thesis, University of Stockholm, 
Sweden). In this work Thermofluor assays carried out by the EMBL HTX platform 
(https://embl.fr/htxlab) (Figure 3.15) show that the H169T mutation causes a significant 
increase in the melting temperature of H169TDntR compared to that of apo-DntR, consistent 
with a difference in conformation. It was therefore postulated that the H169T mutant of 
DntR might adopt an active conformation and it was therefore decided to study the 
structure of this mutant both in crystals and in solution.  
 
Figure 3.15: Thermofluor assays of apo- and holo-DntR and apo-H169TDntR. Introducing the H169T mutation 
caused a shift in melting temperature of DntR. The assays were conducted by the EMBL high throughput 
crystallisation laboratory (https://embl.fr/htxlab/). All protein concentrations were ~5 mg/ml. In the case of 
holo-DntR 100 µM sodium salicylate was added to the sample. 
3.2.1 Crystallization of H169TDntR 
 
Crystals of the constitutively active H169T mutant of DntR (H169TDntR) could be produced 
in either of the conditions that produced apo-DntR and thiocyanate-bound DntR (Section 
2.3.1). 
However, crystals grown in the absence of thiocyanate (Figure 3.16B) diffracted only to 
dmin~12 Å and were not pursued further (see Section 2.3.2). Those grown in the presence of 
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thiocyanate (Figure 3.16A) showed diffraction to dmin~3.3 Å. Full diffraction data collection, 
structure solution and refinement (Table 3.3) were therefore carried out using a single 
crystal of thiocyanate-bound H169TDntR. As can be seen from Table 3.3 the crystals of 
thiocyanate-bound H169TDntR obtained are isomorphous to those obtained for apo-DntR 
(this work), thiocyanate- or acetate-bound DntR (Smirnova et al., 2004) and other single 
point mutants of DntR (Lönneborg et al., 2007). The crystal structure of H169T is virtually 
identical to these. As for the crystal structure determined in (Lönneborg et al., 2007; 
Smirnova et al., 2004) the electron density for the wHTH dimers that flank the central core is 
very weak. These regions were thus not modelled and the crystal structure of H169TDntR 
thus consists of the central IBD tetrameric core which as for other crystal structure of full-
length DntR homotetramers adopts a compact conformation (Figure 3.7). 
 
 
Figure 3.16: Crystals of H169TDntR. (A): Crystals H169TDntR grown in the presence thiocyanate. (B): Crystals of 
H169TDntR grown in the absence of thiocyanate. 
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Dataset H169T DntR 
Beam-line 
Wavelength  
ID23-1 (ESRF) 
0.976 
Space group P 6522 
Unit cell dimensions:  
   a,b,c (Å) 107.47 107.47 299.77 
   α,β,γ (°) 90.00  90.00 120.00 
Resolution range (Å) 47.14 - 3.30 
Number of unique reflections 16123 
Multiplicity 5.5 (5.6) 
Completeness (%) 99.7 (100) 
Rmerge  0.179 (0.951) 
<I/σI>  10.9 (2.6) 
Wilson B factor 88.799 
 
Refined model composition 
 
Molecule A 
Molecule B 
Thiocyanate Ions 
S89-R302 
R87-E300 
2 
 
 
Model quality indicators 
 
R-factor (%) 18.82 
Free R-factor (%) 24.03 
RMS deviations:  
   Bonds (Å) 0.007 
   Angles (°)  0.972 
 
 
B factors 
 
<B> protein 76.20 
<B> thiocyanate 86.29 
  
Ramachandran analysis (%)  
Favored regions 97.18 
Generously allowed regions 2.82 
Disallowed regions 0.0 
  
Table 3.3: Data collection and refinement statistics for the crystal structure of H169TDntR. Figures in 
parentheses are for the highest resolution range for the data set (3.48-3.3 Å). 
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Figure 3.17: The crystal structure of H169TDntR. Top: The asymmetric unit observed in the crystal structure of 
H169TDntR. Middle: The structure of the H169TDntR IBD tetramer constructed based on symmetry related 
molecules such that they have coordinates (x, y, z) and (1-x, y, ½-z). Bottom: Superposition of the crystal 
structure H169TDntR (yellow and green) and the solution structure of apo-DntR (black). The r.m.s. deviation in 
cα positions is 0.41 Å based on 431 residues aligned. 
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However, while the global structure of the IBD core of H169TDntR and apo-DntR are 
extremely similar, at a local level there is one very significant difference, specifically a 
superposition of the IBCs (Figure 3.18, left) seen in the crystal structures of apo-DntR and 
H169TDntR reveals that the H169T mutation results in a much more open binding site 
reminiscent of that observed in the IBC of salicylate-bound ΔN90DntR (Figure 3.18, right). 
The crystal structure of H169TDntR thus allows for two possible interpretations:  
1) The active form of DntR homotetramers maintains a closed tetrameric 
conformation but with more open IBCs. 
However this does not explain the results of the thermofluor assays (Figure 3.15) which is 
consistent with different conformations for H169TDntR so another interpretation is: 
2) Crystal packing forces H169TDntR to adopt an inactive homotetrameric state in the 
crystal form obtained. 
 
Figure 3.18: Superposition of the IBCs seen in the crystal structures of apo-DntR, H169TDntR and holo-
ΔN90DntR. Left: The IBC of H169TDntR (blue carbon atoms) superposed with IBC of apo-DntR (grey carbon 
atoms). Right: The IBC of H169TDntR (blue carbon atoms) superposed with IBC of salicylate-bound ΔN90-DntR 
(yellow carbon atoms). 
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3.2.2 Small Angle X-ray Scattering analysis H169TDntR 
 
To examine the structure of apo-H169TDntR in solution, SAXS experiments were performed 
(Section 2.4.1.3). H169TDntR showed a higher propensity to aggregate than did DntR and to 
avoid any interparticle interactions the concentration of solutions of H169T used in SAXS 
experiments was kept at 0.7 mg/ml. In order to achieve higher resolution data than 
otherwise would have been the case, 10 x 10 frames, each of for 2 seconds exposure time, 
were averaged to produce the experimental scattering curve (Figure 3.19, top). 
Analysis of the Guinier region of the scattering curve yielded a Rg value of 42 Å (Table 3.4) 
which is significantly larger than that seen in the solution structure (38.8 Å) of the apo-DntR 
tetramer. The pair distribution (P(r)) function derived from the scattering curve (Figure 3.19, 
bottom) indicates a Dmax of 135 Å (Table 3.4), which is significantly longer than the maximum 
distance (118 Å) observed in the solution structure of full length apo-DntR (Figure 3.8) but is 
however a close fit to what was observed in the crystal structure of apo-DntR (130 Å). 
 
Invariant Parameter Solution structure 
apo-DntR 
Solution structure 
apo-H169TDntR 
Crystal structure 
apo-DntR 
Dmax (Å) 118  135  130 
Rg (Å) 38.8 +/- 0.6  41.9 +/- 0.5   
 
Table 3.4: Comparison of invariant parameters obtained from solution scattering curves for apo-DntR and 
apo-H169TDntR.  
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Figure 3.19: SAXS scattering curve and corresponding Guinier region and P(r) function for apo-H169TDntR. 
Top: Scattering curve displaying log(I) as a function of q. Insert: Guinier region data points (black) and the 
resulting fit derived from AUTOGNOM (red) which yielded Rg= 41.9 Å. Bottom: SAXS-derived Pair Distribution 
Function of full length H169TDntR yielding Dmax=135. The function was generated by indirect Fourier 
transformation using the program GNOM.  
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3.2.2.1 Molecular envelopes of the solution structures of apo-H169TDntR 
 
ab initio envelopes of the solution structure of apo-H169TDntR were created in DAMMIF 
based on the P(r) function shown in Figure 3.19. Twenty independent models were obtained, 
applying p22 symmetry restrictions, and averaged with DAMAVER. The result is shown in 
Figure 3.21. The envelope obtained suggests that in solution H169TDntR adopts much more 
elongated conformation than that seen for the solution structure of apo-DntR. Moreover, 
the envelope obtained is more consistent with the open-form homotetramer structure of 
the TsaR derived homology model (Figure 3.20, bottom). This observation is reinforced by 
the results of CRYSOL fits of the experimental scattering curves vs. the theoretical scattering 
curves based on other structural models. 
Model χ2 
Apo-Solution Structure 3.38 
Apo-Crystal Structure  2.45  
TsaR Homology Model 1.47 
 
Table 3.5: χ
2
 values obtained for the CRYSOL fits shown in Figure 3.20. 
As can be seen in both Table 3.5 the calculated scattering curve based on the solution 
structure apo-DntR as described previously (Section 3.1.2) is a very poor fit to the 
experimentally obtained scattering curve for apo-H169TDntR. Moreover, while a calculated 
scattering curve based on the crystal structure of apo-DntR tetramer (Section 3.1.2.1) 
produces an improved, fit it is clear that a calculated scattering curve based on the open 
form DntR homology model based on the structure of TsaR model provides a better fit than 
the theoretical curves of both other structures.  
Rigid body modelling was attempted but the scattering data proved insufficient as multiple 
runs did not converge towards a single model and modelling was therefore abandoned. 
Nevertheless both the ab initio envelopes obtained and CRYSOL the fitting of an 
experimental and calculated scattering curve suggest that in solution H169TDntR tetramers 
adopt a open-form TsaR-like conformation. 
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Figure 3.20: SAXS analysis of apo-H169TDntR - CRYSOL fits against the experimental scattering data. To avoid 
any interference from interparticle effects the first few data points were omitted. Top: Theoretical scattering 
curve of Solution structure of apo-DntR as generated by SASREF (red) vs. the experimental scattering curve for 
apo-H169TDntR (black). Middle: Theoretical scattering curve of the crystal structure of full length apo-DntR 
(red) vs. the experimental scattering curve for apo-H169TDntR (black). Bottom: Theoretical scattering curve of 
the open-form DntR homology model (red) vs. the experimental scattering curve for apo-H169TDntR (black). 
The resulting χ
2
 values of the fits are shown as insert is and in Table 3.6. 
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Figure 3.21: ab initio envelope of the solution structure of H169TDntR. Top: ab initio envelope manually 
overlaid with the previously determined (Section 3.2.2.2) solution structure of apo-DntR. Bottom ab initio 
envelope overlaid with open-form DntR homology model based on the crystal structure of TsaR. 
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3.2.2.2 Comparison of the results of SAXS experiments concerning apo-DntR and apo-
H169TDntR 
 
The results presented above highlight a case in which different proteins have the same 
crystal structure but have markedly different structures in solution. The SAXS studies 
described above clearly also show that while apo-DntR maintains a closed tetrameric 
conformation in solution, H169TDntR does not.  For apo-H169T DntR SAXS derived 
parameters (Rg, Dmax; Table 3.5) indicate a structure slightly more elongated than seen in the 
crystal structure. This evidence is further supported by ab initio models and CRYSOL fits of 
theoretical scattering curves to the experimental data which suggest that in solution the 
H169TDntR homotetramer has a structure close to that of the open form tetramer seen in 
the crystal structure of TsaR. That H169TDntR shows activity even in the absence of its 
inducer molecule salicylate suggests that it adopts an activated conformation. This suggests 
that the open conformation observed in TsaR is indeed the activated state of an LTTR 
protein. The results of the SAXS studies of apo-DntR and apo-H169TDntR thus appear to 
confirm the hypothesis (Devesse et al., 2011; Monferrer et al., 2010) that upon activation 
LTTR homotetramers change conformation from a compact homotetrameric state to a more 
open state. 
3.3 Conclusions on inducer-free DntR 
 
The solution structures presented herein show that DntR in its apo state does indeed 
present a compact conformation. The crystal structure of apo-DntR shows that the 
conformation of the IBC in the apo state prevents inducer molecules from binding. The 
current hypothesis (Devesse et al., 2011; Monferrer et al., 2010) of LTTR activation is that 
inducer binding results in a change of conformation of the IBC which translates into a 
movement of the hinge region in the IBDs causing a closure of the IBDs and a transition into 
a more extended homotetramer. This model seems to be confirmed by the crystallographic 
studies of H169TDntR presented here. X-ray crystallography shows that the IBCs in 
H169TDntR, which can activate transcription in the absence of an inducer molecule, adopt a 
conformation more similar to those seen in the IBCs of salicylate-bound DntR than the IBCs 
of apo-DntR. However, SAXS studies show that in solution H169TDntR homotetramers adopt 
an open and elongated conformation. The hypothesis that the solution structure of 
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H169TDntR is really that of an activated DntR homotetramer needs, however, to be 
confirmed by in solution studies of DntR in presence of its inducer molecule salicylate. 
3.4 Small Angle X-ray Scattering analysis of DntR in complex with salicylate 
 
The SAXS results obtained from solutions of H169TDntR coupled with evidence that this 
mutant is constituently active and thermofluor studies indicating that the mutant adopts a 
different conformation than apo-DntR (Figure 3.15) suggests that the active form of DntR is 
similar to the open form tetramers seen in the crystal structures of TsaR (Monferrer et al., 
2010). To confirm this suggestion, SAXS scattering curves from solutions of DntR pre-
incubated sodium salicylate in concentrations of 20, 100 and 5000 µM were measured as 
outlined in Section 2.4. Measurements of the scattering curves from solutions of apo-DntR 
were also repeated and showed results similar to those previously obtained Section 3.1.2. 
The resulting scattering curves observed from solutions of DntR pre-incubated with sodium 
salicylate are shown in Figure 3.22. Invariant parameters (Rg, I(0), Dmax) were obtained using 
AUTORG and AUTOGNOM. The results are displayed in Figure 3.22, 3.23 and 3.24 and Table 
3.6. Although the I(0) values cannot be correlated with an absolute molecular mass due to 
high glycerol concentration (see Section 3.1.2) it can still be used arbitrarily to compare the 
different samples.  
The addition of 20 µM sodium salicylate shows no significant changes in invariant 
parameters compared to the values obtained from solutions of apo-DntR. Pre-incubation 
with 100 µM sodium salicylate yields increased values of Rg and Dmax compared to those of 
apo-DntR. However, the values of I(0) and Porod volume do not increase significantly 
suggesting that changes in this scattering curve compared to that obtained for apo-DntR can 
be attributed to structural differences.  
[salicylate] µM Rg (Å) I(0)  Dmax (Å) Porod volume nm
3 
0 38.4 (+/-0.6) 4.97 (+/- 0.04) 118 262.85 
20 39.2 (+/-0.4) 5.18 (+/-0.02) 120 262.50 
100 41.4 (+/- 0.4) 5.22 (+/-0.03) 142 262.19 
5000 44.1 (+/- 0.4) 5.88 (+/-0.04) 147 296.89 
Table 3.6: Invariant parameters obtained from SAXS scattering curves from solutions of apo-DntR and of 
DntR pre-incubated with different concentrations of sodium salicylate. Parameters obtained as a function of 
salicylate. 
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As pre-incubation with sodium salicylate should not significantly increase the molecular 
weight of the DntR sample under study (salicylate mw 138 Da), any large increase in I(0) and 
in Porod Volume (Table 3.6) is problematic as this may indicate interparticle interactions 
(Putnam et al., 2007). The large change in the Porod Volume and I(0) value upon addition of 
5000 µM sodium salicylate indicates the introduction of sufficient inter-particle effects to 
make this scattering curve unreliable for further analysis. Determination of the solution 
structures of salicylate-bound DntR was therefore based on SAXS scattering curves 
measured from a solution of DntR pre-incubated with 100 µM sodium salicylate. 
 
Figure 3.22: Solution scattering curves obtained from solutions of DntR pre-incubated with various 
concentrations of sodium salicylate. Scattering curve displaying log(I) as a function of q for DntR pre-incubated 
with 20 µM (top), 100 µM (middle), and 5000 µM (bottom) sodium salicylate. The curves are displayed within 
the data range q = 0-0.25 Å. 
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Figure 3.23: The Guinier regions of scattering curves obtained from solutions of DntR pre-incubated with 
salicylate. Guinier regions data points (black) and the resulting fit (red) derived from AUTOGNOM for solutions 
of DntR pre-incubated with 20 µM (Top), 100 µM (Middle) and 5000 µM (Bottom) sodium salicylate. The Rg 
values are shown in inserts. 
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Figure 3.24: P(r) functions of the scattering curves shown in Figure 3.22. P(r) functions of the scattering curves 
obtained in the presence of 20 µM (Top), 100 µM (Middle) and 5000 µM (Bottom) sodium salicylate.  
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3.4.1 Solution structure of DntR pre-incubated with 100 µM salicylate 
 
The solution scattering curve measured from DntR pre-incubated with 100 M sodium 
salicylate was used to produce ab initio molecular envelopes (Figure 3.25) of the solution 
structure of salicylate-bound, and presumably activated, DntR. Here, to reduce bias, 
modelling was conducted without symmetry restrictions. The envelope obtained is clearly 
more similar in nature to the envelope obtained (Figure 3.21) for the H169TDntR 
homotetramer than that for the apo-DntR homotetramer (Figure 3.10). It is also evident that 
the crystal structure of the apo-DntR (Section 3.1) and the open-form TsaR-like homology 
model of a DntR homotetramer, described earlier (Section 3.4.3), fit the envelope much 
better than the solution structure of apo-DntR obtained in section 3.1.2. 
The solution scattering curve obtained in the presence of 100 µM sodium salicylate was 
compared, using CRYSOL, to the calculated scattering curves based on the crystal structure 
of apo-DntR, the TsaR homology model of the open form of a DntR homotetramer and the 
SASREF-obtained solution structure for apo-DntR. These resulting fits (Figure 3.26) make it 
evident that calculated scattering curves of the crystal and solution structures of apo-DntR 
homotetramers determined during this work, provide poor fits to the experimental data. 
However, the theoretical curve calculated using the TsaR type homology model of an open-
form DntR tetramer shows a much better fit, indicating that the solution structure of 
salicylate-bound DntR is more similar to this structure than to the compact tetramers seen in 
either the crystal or solution structures of apo-DntR described here. Thus, as was the case 
for H169TDntR (Section 3.2), the invariant parameters, CRYSOL fits and ab initio envelopes 
derived from SAXS experiments on solutions of salicylate-bound DntR, are all consistent with 
a DntR tetramer that is closer in conformation to an open TsaR-type tetramer than to the 
compact tetrameric structure obtained for the solution structure of apo-DntR. 
3.4.2 Rigid body modeling 
 
Rigid body modelling of the solution structure of salicylate-bound DntR was performed in 
SASREF using the same restraints as applied for apo-DntR (Section 3.1.2.2). The result shown 
in Figure 3.21, is consistent with the ab initio envelopes obtained and with CRYSOL fits (see 
above) clearly indicating that in solution holo- DntR homotetramers adopt a conformation 
very reminiscent of the open-form tetramers  seen in the crystal structure of TsaR.  
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Figure 3.25: SAXS determined ab initio molecular envelope of salicylate-bound DntR overlaid with different 
models of the structure of full length DntR tetramer. Envelopes were based on 20 independent DAMMIF runs 
averaged and filtered with DAMAVER, were constructed without any symmetry restrictions and manually 
overlaid with the TsaR-like open-form DntR homology model (top), the crystal structure of apo-DntR (middle) 
and the solution structure of apo-DntR previously generated (bottom). 
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Figure 3.26: SAXS analysis of a solution of DntR pre-incubated with 100 µM sodium salicylate - CRYSOL fits 
against the experimental data. Top: Theoretical scattering curve calculated from solution structure of apo-
DntR as generated by SASREF (red) vs. the experimental scattering curve obtained from a solution of DntR pre-
incubated with 100 µM sodium salicylate (black). Middle: Theoretical scattering curve calculated from the 
crystal structure of apo-DntR (red) vs. the experimental scattering curve obtained from a solution of DntR pre-
incubated with 100 µM sodium salicylate (black). Bottom: Theoretical scattering curve calculated from the 
open-form DntR homology model(red) vs. the experimental scattering curve obtained from a solution of DntR 
pre-incubated with 100 µM sodium salicylate (black). ). The resulting χ
2
 values of the fits are shown as inserts. 
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Figure 3.27: The SASREF-obtained solution structure of salicylate-bound DntR. Top SASREF-generated rigid 
body model of the solution structure of salicylate-bound DntR overlaid with the ab initio envelope obtained. 
Bottom: Theoretical scattering curve calculated from the SASREF-generated model (red) vs. the experimental 
scattering curve obtained from a solution of DntR pre-incubated with 100 µM sodium salicylate. The χ
2
 value 
showed as an insert. The poor fit at higher q range may be caused by local differences between the model 
obtained and the true solution structure.  
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As can be seen in Figure 3.27, scattering curves calculated from the SASREF generated 
solution structure appears to be a good match for the experimental scattering data. 
However the poor fit at high q values indicates that there are local differences probably 
caused by the inflexibility of the rigid bodies used in the SASREF procedure between the 
structure generated and the actual conformation of the protein in solution. To try to obtain a 
better fit of the theoretical curve to the experimental data, the IBDs in the SASREF generated 
solution structure were replaced with those observed for the doubly-salicylate-bound IBDs 
seen in the crystal structure of holo-ΔN90DntR (PDB 2Y7K, chain A and B) (Devesse et al., 
2011). Here the IBCs are expanded to accommodate salicylate and the IBD is slightly closed 
around the salicylate bound in the IBC. This replacement resulted in a theoretical scattering 
curve that provides a good fit to the experimental scattering data over the entire q range 
(Figure 3.28). 
 
 
Figure 3.28: SAXS analysis of salicylate-bound DntR - CRYSOL fits against the experimental data. Theoretical 
scattering curve calculated from the the SASREF-generated solution structure of salicylate-bound DntR in which 
the IBds are closed (red) vs. the experimental scattering curve obtained from a solution of DntR pre-incubated 
with 100 µM sodium salicylate (black). The χ
2
 value is shown as an insert. 
Χ2 = 1.03 
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3.4.3 Conclusions 
 
The results of the SAXS studies in a solution of salicylate-bound DntR described above are 
consistent with those observed for the constituently active H169TDntR and provide further 
evidence that upon activation DntR homotetramers undergo a conformational change such 
that they adopt a quaternary structure close to that seen in the crystal structure of TsaR 
(Monferrer et al., 2010). The solution structure of salicylate-bound DntR thus supports the 
hypothesis that upon inducer binding, activation of LTTR homotetramers involves a change 
in conformation from a compact to an open tetrameric configuration. However, given the 
propensity of LTTR proteins to aggregate (Section 1.3.2), to rule out that the results obtained 
thus far are artefacts due to interparticle interactions, it was deemed necessary to perform 
SAXS experiments coupled with online size exclusion chromatography. 
3.5 HPLC-coupled SAXS 
 
In order to verify that the observed differences in solution scattering curves and the 
resulting molecular envelopes and structural models between the apo- and holo- states of 
DntR were due to real conformational changes and not caused by small amounts of 
interparticle interactions in the presence of sodium salicylate, SAXS experiments were 
repeated, this time coupled with size exclusion chromatography (see Section 2.4.2 for 
experimental details). The solutions of DntR were applied to a gel filtration column and the 
resulting eluent exposed directly to the X-ray beam. The elution profiles of apo-DntR and 
DntR pre-incubated with 5 mM sodium salicylate are shown in Figure 3.29 which evidences a 
clear difference in the behaviour of apo- and holo-DntR. A total of 3500 frames were 
collected for each gel filtration run and frames which had near identical Rg values as 
determined by AUTOGNOM (Figures 2.19, 2.20 and 3.29), were pooled for manual 
processing and averaged. The resulting scattering curves are shown in Figure 3.30. 
The scattering curves obtained are much noisier than those obtained from the static SAXS 
measurements described earlier (Section 3.1.2) as the concentration of protein in the eluent 
is much lower than that used in static SAXS measurements. Nevertheless, it is still possible to 
obtain satisfactory Guinier regions and P(r) plots (Figure 3.31) from which the invariant 
parameters shown in Table 3.7 were derived. 
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Figure 3.29: The online gel filtration elution profiles of solutions of apo- and holo-DntR. apo-DntR (blue) and 
apo-DntR having been pre-incubated with 5 mM sodium salicylate for 30 minutes (red). For the latter 100 M 
sodium salicylate was also added to the elution buffer. Both runs were conducted with a flow rate of 0.5 
ml/min. The position of the frames that were used for manual data processing are shown (red lines for holo-
DntR, blue lines for apo-DntR). 
 
117 
 
 
Figure 3.30: Averaged solution scattering curves for gel filtrated apo-(top) and holo-DntR (bottom). Solution 
scattering curve displaying log(I) as a function of q. To obtain the curves, approximately 80 frames were 
averaged in both cases. The scattering curves are displayed in the q range 0 -0.15 Å
-1
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Figure 3.31: Guinier plots and P(r) functions obtained of apo-DntR and DntR pre-incubated with 5 mM 
salicylate. Guinier regions data points (black) and the resulting fit (red) derived from AUTOGNOM for solutions 
of apo-DntR (Top) and holo-DntR (Middle). Bottom: P(r) functions of apo-DntR (blue) and holo-DntR (red). 
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[salicylate] µM Rg (Å) I(0)  Dmax (Å) Porod volume nm
3 
0 39.1 (+/-0.5) 4.9 (+/- 0.03) 118 253.3 
5000 41.7 (+/-0.5) 5.2 (+/-0.02) 141 255.2 
 
Table 3.7: Invariant parameters obtained from gel filtrated SAXS scattering curves of DntR in the absence and 
presence of 5 mM sodium salicylate. Values were obtained from plots shown in Figure 3.31. 
As was the case with static measurements, the invariant parameters indicate that DntR 
undergoes a conformational change upon the binding of salicylate.Moreover, while the 
lowered signal to noise ratio and a smaller useable q range in the HPLC-coupled SAXS 
experiments cause ab initio models obtained from SAXS experiments on solutions subject to 
gel-filtration immediately before scattering curve measurements to contain fewer features 
than those obtained in static measurements (data not shown), the values for Rg and Dmax 
derived from such experiments are near identical to those obtained in static measurements. 
This strongly suggests that the structural models derived from higher q-range static SAXS 
experiments are valid (i.e. not affected by aggregation), as are conclusions concerning the 
conformational status of activate and inactive DntR that are based on these. 
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4 Discussion 
4.1 Summary of results 
4.1.1 X-ray crystallography 
 
This work utilized X-ray crystallography to investigate the crystal structures of DntR in its 
apo- state and of the constitutively active mutant H169TDntR.  
4.1.1.1 apo-DntR 
 
The crystal structure of apo-DntR presented in Figure 3.2 is iso-structural to previous DntR 
crystal structures solved in complex with either thiocyanate or acetate (Smirnova et al., 
2004). The electron density of the two N-terminal wHTH/linker helix domains of the two 
DntR monomers in the asymmetric unit is more well defined than in the previously reported 
DntR crystal structures and allowed for a complete description of the crystal structure of the 
apo-DntR homotetramer. The crystal structure obtained essentially confirms the model of 
the DntR tetramer previously suggested by (Smirnova et al., 2004). However, the crystal 
structure of apo-DntR also disputes the hypothesis made by Smirnova and colleagues that 
the ion-bound structures they determined represented DntR homotetramers in an active 
conformation. Indeed, a comparison of the configuration of the IBCs in the crystal structure 
for apo-DntR obtained here and in the crystal structures of ion-bound DntRs shows that in 
the latter the IBCs cannot bind salicylate and suggests that the conformation for DntR 
homotetramers observed by Smirnova and colleagues is actually that of DntR in an inactive 
state. 
4.1.1.2 H169TDntR 
 
The crystals of the constitutively active H169TDntR obtained during this thesis work have 
very similar unit cell dimensions (Table 3.3) to those obtained for apo-DntR (Table 3.1) and 
the resulting crystal structures are also near identical. However, the IBCs of H169TDntR 
monomers adopt a much more open conformation, similar to the observed in salicylate-
bound ΔN90DntR. The ability to induce transcription without a ligand suggests that apo-
H169TDntR adopts an activated conformation much more readily than does apo-DntR. The 
activated state of DntR has already been proposed to be caused by a closure of the DntR IBD 
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which may be rendered more favourable by the opening of the IBC as seen in the crystal 
structure of H169TDntR. 
4.1.2 SAXS 
 
To examine the in-solution structures of DntR, free of crystal packing effects, SAXS 
experiments were performed on solutions of apo- and holo-DntR and on a solution of 
H169TDntR. 
4.1.2.1 apo-DntR 
 
The invariant parameters obtained from solution scattering curves from solutions of apo-
DntR showed some discrepancy to those expected from the compact homotetrameric crystal 
structure of apo-DntR and suggested that in solution DntR homotetramers in the apo- state 
in solution are less elongated than is observed in its crystal structure. To obtain a proper 
model of the solution structure of apo-DntR homotetramers rigid body modelling was 
carried out against the experimentally obtained SAXS scattering curve. The resulting model 
provides a good fit to both the scattering curve and the ab initio model envelopes obtained. 
The resulting solution structure does not greatly change in quaternary structure compared 
to the crystal structure of the apo-DntR homotetramer. However, there is a clear change in 
the positions of the wHTH dimers flanking the central tetrameric IBD core. These pack more 
closely to the core than is observed in the crystal structure. A theoretical scattering curve 
calculated using an open-form DntR homology model based on the crystal structure of TsaR 
did not provide a good fit to the experimental scattering curve thus excluding the hypothesis 
that, in solution, apo-DntR would adopt an open homotetrameric form. 
4.1.2.2 H169TDntR 
 
The invariant parameters obtained from scattering curves measured from solutions of 
H169TDntR indicated a solution structure that is slightly more elongated than the solution 
structure of apo-DntR. Here, CRYSOL fits and ab initio envelopes showed consistently better 
fits to the open-form DntR homology model based on the crystal structure of TsaR 
suggesting that the constitutively active H169TDntR has a similar structure. Taken together 
with the solution structure of apo-DntR homotetramers determined during this work (see 
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above) this strongly supports the idea that upon activation DntR homotetramers change 
conformation from a compact to a more open form. 
4.1.2.3 holo-DntR 
 
To confirm the above suggestion, a solution of holo-DntR was created through the pre-
incubation of apo-DntR with 100 µM sodium salicylate. The invariant parameters obtained 
from the resulting SAXS scattering curves were similar to those obtained for H169TDntR, 
indicating, in solution, a more elongated quaternary structure for holo-DntR than for apo-
DntR. As was the case for H169TDntR, CRYSOL fits of a theoretical scattering curve calculated 
using the open-form DntR homology model showed better fit to the experimental data than 
did scattering curves calculated using either the solution or crystal structures of apo-DntR 
determined during this work. 
Rigid body modeling using SASREF resulted in a holo-DntR solution structure similar to that 
of the crystal structure of TsaR in which the LTTR homotetramer adopts an elongated 
conformation with a central cavity between the two IBD dimers in the homotetramer 
observed. The model of the solution strucure of holo-DntR homotetramers model could be 
modified to produce a CRYSOL fit in which χ2 = 1.03 by the replacement of the IBD dimers 
with those observed in the crystal structure of doubly salicylate-bound ΔN90 DntR (PDB 
2y7k, page 97). 
4.1.2.4 Gel filtrated samples 
 
Gel-filtration-coupled SAXS experiments were carried out in order to test whether or not the 
differences in DntR homotetramer conformation observed for apo- and holo-DntR in static 
SAXS experiments were, in fact, artefacts caused by a small amount of aggregation upon the 
addition of 100 µM sodium salicylate to solutions of apo-DntR. Table 4.1 shows a reminder 
of the invariant parameters derived in the various static and HPLC-coupled experiments 
carried out. As can be seen, the values for these parameters derived from solutions subject 
to gel-filtration immediately before scattering curve measurements are near identical to 
those obtained in static measurements. This strongly suggests that the structural models 
derived from higher q-range static SAXS experiments are valid (i.e. not affected by 
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aggregation), as are conclusions concerning the conformational status of activate and 
inactive DntR that are based on these. 
Static Measurements Gel Filtrated Sample 
[salicylate] µM Rg (Å) Dmax (Å) [salicylate] µM Rg (Å) Dmax (Å) 
      
0 38.4 (+/-0.6) 118 0 39.2 (+/-0.5) 118 
100 41.4 (+/-0.4) 142 5000 41.7 (+/-0.5) 141 
 
Table 4.1: invariant SAXS parameters obtained for apo- and holo-DntR with and without gel filtration prior to 
measurements. 
4.2 The inactive and active states of DntR 
 
The current consensus is that LTTRs regulate transcription through large conformational 
changes, which would modify the conformation of bound DNA, upon inducer binding. While 
previous structural studies (Devesse et al., 2011b; Monferrer et al., 2010b) have suggested 
that the conformational change in question is a movement from compact to open form 
homotetramers no LTTR has yet been observed to adopt both configurations. The results of 
the SAXS studies on solutions of apo-DntR, H169TDntR and salicylate-bound DntR here 
provides the first unequivocal evidence that a LTTR can indeed adopt both conformations 
(Figure 4.1, left). SAXS studies of apo-DntR shows that in solution, inactive DntR 
homotetramers adopt a conformation that is more compact than observed in the crystal 
structures of either ion-bound (Smirnova et al. 2004) or apo-DntR (this work). Of particular 
interest in the solution structure of apo-DntR homotetramers is the wHTH DBD dimers. 
These pack much more closely to the tetrameric core than seen in crystal structures and 
adopt a conformation which would cause the T-N11-A regions bound to these motifs to be 
almost parallel (Figure 4.2, top). 
The SAXS studies reported here for holo-DntR and the constitutively active H169TDntR 
suggest a markedly different conformation for the structure of activated DntR 
homotetramers. Here the conformation observed for DntR homotetramers is close to that 
seen in the crystal structure of TsaR. In the open form homotetramers observed the IBD 
dimers making up the central core of the homotetramer are separated creating a central 
cavity (Figure 4.1, right) while the wHTH N-terminal domains are displaced such that the 
bound T-N11-A DNA motifs would adopt an angle to each other of approximately 30 degrees 
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(Figure 4.2, bottom). Intriguingly, comparing the solution structures of apo- and holo- DntR 
with the crystal structure of apo-DntR it appears that the latter shows a DntR homotetramer 
in an intermediate state between active and inactive states (Figure 4.2, middle). Without 
either DNA or inducer molecules bound,the wHTH DBD dimers appear to show some degree 
of flexibility allowing this intermediate state to occur. It is worth noting that in the models 
shown in Figure 4.2, a relaxing of the bend in bound promoter region DNA can only occur if 
the binding site for one (or both) of the DntR DBD dimers is displaced. This would have the 
effect of pushing the promoter region away from DntR thus making it available for RNA 
polymerase. A shift such as this was observed for the clcA gene as described in Section 1.3.1. 
  
Figure 4.1: Orthogonal views of the solution structures of apo- and holo-DntR. SASREF-generated solution 
structures of apo-DntR (left) and holo-DntR (right) homotetramers. The distances between the two IBD 
dimers making up the central core of the homotetramers are depicted as are the overall dimensions of the 
homotetramers themselves. 
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Figure 4.2: Side views of the models of DNA binding position of the N-terminal wHTH/linker helix domains in 
the various DntR homotetramers observed. The position of bound DNA was based on alignments with the 
crystal structure of the BenM DNA-wHTH/linker helix domain in complex with DNA (Alanazi et al., 2013b). The 
models shown are: DNA binding to the wHTH domains of the solution structure of apo-DntR (top); DNA binding 
to the wHTH domains as seen in the crystal structure of apo-DntR (middle) and DNA binding to the wHTH 
domains as seen in the solution structure of salicylate-bound DntR (bottom). 
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Figure 4.3: The possible displacement of a binding site for bound DNA upon DntR activation. In order to relax 
the bend of bound promoter region DNA the binding site for one (or both) of the DntR DBD dimers must be 
displaced. This would have the effect of pushing the ABS site (red) of the promoter region away from DntR thus 
making it available for RNA polymerase. 
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Figure 4.4: Comparison of the solution structure of holo-DntR and the crystal structure of TsaR. Orthogonal 
views of the solution structure of salicylate bound DntR (left) and the crystal structure of Tsar (right). 
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4.3 The activation of LTTR proteins 
 
In their recent paper Devesse et al. (Devesse et al., 2011) presented crystal structures of 
both apo- and salicylate-bound ΔN90DNTR. For some of the structures presented ΔN90DNTR 
adopted a closed conformation. Comparing this conformation with that of the Inducer 
Binding Domains observed in the crystal structure of homotetrameric TsaR (Monferrer et al., 
2010) provided evidence to support the hypothesis made by Monferrer and co-workers that 
inactive LTTR tetramers adopted a compact conformation while active, inducer-bound, 
LTTRs take up a more extended form. However, while the crystal structures of several LTTR 
proteins have shown that they can adopt either compact or extended conformations, to 
date no LTTR has been observed to adopt both configurations. Moreover, assignment as to 
whether a crystal structure represents a particular LTTR in an inactive or active state has 
been complicated by the fact that the occupancy of the IBCs in LTTR crystal structures does 
not necessarily correlate with the observation of compact/extended homotetramers. 
The work described here is the first time that a LTTR has been observed to adopt both 
compact and open configurations: A combination of X-ray crystallography and SAXS clearly 
shows that inactive apo-DntR homotetramers adopt a compact conformation while 
activated holo-DntR homotetramers adopt an open configuration very similar to that 
observed in the crystal structure of TsaR (Figure 4.4). The hypotheses made by (Devesse et 
al., 2011) and (Monferrer et al., 2010) have thus been confirmed and it is clear that LTTR 
homotetramers are activated as schematised in Figure 4.5. Here, inactive LTTR 
homotetramers adopt a compact conformation in which the two head-to-tail C-terminal IBD 
dimers associate to form a tetrameric core in which the IBCs adopt a conformation that is 
inconsistent with inducer molecule binding. This central tetrameric core is flanked by two 
dimeric wHTH DNA binding domains that are parallel with respect to each other, causes 
bound promoter region DNA to inaccessible for RNA polymerase. 
Inducer binding to the IBCs in the central tetrameric IBD core causes these to expand. 
Allowing a hinge movement of IBD monomers such that they close around the bound 
inducer molecule. To avoid steric clashes caused by this hinge movement the compact 
nature of the central IBD core is abolished. This opening of the tetrameric core then causes 
movement of the dimeric DNA binding domains allows space for the N-terminal wHTH 
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domains to adopt a flatter interface with bound DNA resulting in a relaxing of the bending 
which can only occur if the binding site for one (or both) of the DntR DBD dimers is 
displaced. This would have the effect of pushing the promoter region away from DntR thus 
making it available for RNA polymerase.  
 
Figure 4.7: LTTR activation as given in the main text. Inactive DntR (transparent) and active DntR (black) 
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 4.4 Future work. 
 
The work presented in this thesis lays the groundwork for studies of interactions between 
DntR and DNA. The suggested displacement of the promoter region binding sites should be 
verified using DNA footprinting studies and could be structurally characterized through the 
use of small angle neutron scattering (SANS) and atomic force microscopy. Through 
deuteration/contrast matching SANS would allow the elucidation of the solution structures 
of DNA-bound apo- and holo-DntR homotetramers. 
To ensure that the results presented here really are representative of all LTTRs it would be 
necessary to repeat them using a different model protein. As TsaR has already been 
crystallized in what is suggested to be an activated state but not an inactive state. SAXS 
experiments on solutions of TsaR would elucidate whether this protein also adopts inactive 
and active conformations similar to those observed here for DntR. 
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5. Appendix: Small Angle X-Ray Scattering 
 
The following section was partially adapted from master’s thesis “Insulin fibrillation inhibited 
with the flavonoids baicalein and epigallocatechin gallate characterized by Thioflavin T 
assays and Small Angle X-ray Scattering” (Lerche, M, University of Copenhagen, Denmark, 
2010). 
5.1 Principles 
 
Small Angle X-Ray Scattering (SAXS) (Figure 5.1) is a powerful structural biology technique. 
Unlike X-ray crystallography it does not require the growth of crystals and can thus be 
utilized to investigate the structure of proteins in solution. SAXS can be used to investigate 
very large complexes, with molecular weights in the mDa range (Putnam et al., 2007). 
While there is no theoretical limit on the resolution that can be obtained for solution 
structures using SAXS, it is still only possible to produce low resolution models in the 5-10 Å 
range (Koch et al., 2003; Mertens and Svergun, 2010). 
 
Figure 5.1: Setup of a SAXS experiment. The X-rays are scattered by the sample and the scattering is recorded 
on a 2-D detector. Image from http://www.saga-ls.jp/images/image/English/Users%20Guide/Beamlines/BL15  
While SAXS and X-ray crystallography have a number of shared characteristics they are 
fundamentally different. X-ray crystallography measures the diffraction of particles in an 
ordered latice in a crystal and then determines the electron density (Putnam et al., 2007). 
SAXS relies on contrast variation and the scattering signal is derived from the difference of 
electron density between the disordered macromolecules of interest and their solvent (Koch 
et al., 2003). This contrast is quite small and its measurements puts severe practical 
limitations on the resolution of SAXS data (Koch et al., 2003). 
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5.1.1 Scattering intensities 
 
The Scattering pattern of a solution containing randomly oriented particles is a function of q 
which is defined as: 
   
         
 
                 
Where 2θ is half the scattering angle and λ is the wavelength of the incident beam. (In some 
literature and programs q can be referred to as s or h, sometimes with slightly different 
definitions (Putnam et al., 2007)). As the wavelength is kept constant, typically around ~1 Å 
and the scattering angle is confined within a low range, typically 0.1-10o, the q range 
measured in a SAXS experiment is approximately 0-0.5 Å-1 (Koch et al., 2003). 
The scattering function for an ideal solution of molecules is defined as: 
                    
                       
A(q)Ώ is a Fourier transformation over the excess scattering length density, and the 
scattering is averaged over all orientations, this average causes the I(q) function to be 
symmetric (Koch et al., 2003). 
To obtain the SAXS scattering curve of a molecule it is necessary to subtract the scattering 
contribution of the relevant buffer in which the molecule is dissolved. The scattering 
contribution from solution is very large and it is thus very important that the buffer sample, 
used to measure its scattering curve, is identical to the buffer containing the sample (Koch et 
al., 2003). The sample container is also responsible for some contribution to total scattering. 
However, this can often be neglected since the same container is usually utilized for both 
sample and buffer and thus subtracted along with buffer contribution(Koch et al., 2003).  
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Figure 5.2: Measuring SAXS scattering curves. (1) and (2) shows the initial scattering curves for a BSA sample in 
buffer and the scattering curve of the buffer alone. (3) Displays the resulting scattering curve obtained by 
subtracting (1) and (2). It is apparent that the level of noise increases as q and thereby the angle is increased 
Figure produced in primusqt. 
 
 
Figure 5.3: Attractive and repulsive interactions. Right: Sample in which SF(c,s) < 1. Attractive intermolecular 
interactions cause an increase in the scattering curve at low q range. These interactions may lead to unspecific 
aggregation which causes the sample to be inappropriate for further analysis. Left: Sample in which SF(c,s) > 1. 
Repulsive intermolecular interactions cause a decline in the scattering curve at low at low q range. Figures 
produced in Primusqt from insulin data. 
Even a sample which is completely monodisperse may suffer from various effects of 
intermolecular interactions which will affect the scattering intensity at low angles. The 
scattering function for such a non-ideal solutions is given by: 
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SF(c,s) is the SAXS structure factor. Although similar in name, this is not to be confused the 
structure factor used in x-ray crystallography. The SAXS structure factor takes intermolecular 
interactions, repulsive or attractive into account. At infinite dilution at which no 
intermolecular interactions takes place, SF(0,q) = 1 (Koch et al., 2003). Repulsive interactions 
result in a structure factor value below 1 which cause the scattering to decrease (Figure 5.3, 
left), attractive interactions has the opposite effect (Figure 5.3, right).. The effects of minor 
repulsive and attractive interactions can be minimised by cropping data the data in the very 
low q range, attractive interactions may however cause unspecific aggregation which can 
invalidate the dataset (Koch et al., 2003; Putnam et al., 2007). 
5.2 Rg and I(0) 
 
The most important parameters in a SAXS experiment are the I(0) and Radius of Gyration (Rg) 
value. The Rg value is the square root of the averaged squared distances of each scatterer 
from the particle center (Putnam et al., 2007). Large molecules will thus be characterized by 
large Rg values. A sphere with a uniform particle density and a radius of 1 has an Rg value of 
√(3/5) (Putnam et al., 2007), thus slightly lower (0.77) than its actual radius. The I(0) value is 
proportional to the number of electrons in the scatterer (Koch et al., 2003). If the exact 
concentration of the particle is known, I(0) can be used to determine the molecular weight.  
Both parameters are extracted from the Guinier approximation which at low q ranges can be 
given as: 
          
      
 
                
 
This equation can be converted into a linear equation: 
                   
   
 
                   
A plot of ln(I(q)) versus q2 will, at low q values in which the Guinier approximation is valid, 
result in a straight line (Figure 5.4). The slope of the curve yields the Rg value while the I(0) is 
the intercept value. Since I(0) is the theoretical intensity measured at zero angle q=0, this 
value must be obtained from extrapolation of the curve (Putnam et al., 2007). 
 
143 
 
 
Figure 5.4: AUTOGNOM Guinier region estimation in primusqt. The experimental data points are shown in 
black, the Guinier fit in red and residuals in green.  
5.2.1 Considerations 
 
The Guinier plot is critical to SAXS analysis. While it is possible to obtain Rg and I(0) values by 
other means, lack of linearity in the Guinier plot usually indicates problem with the sample 
(Koch et al., 2003). 
The Guinier approximation as only valid in the Guinier region, the region in which a plot of 
ln(I(s)) versus s2, results in a straight line. This will not be the case at high q values, but any 
structure factors at low q values will also result in a non straight line. 
The program Primus from the Atsas package contains an AutoRg function (Figure 5.4) which 
attempts to fit the Guinier region providing values for Rg Dmax and I(0). While the parameters 
obtained serve as a good guideline, the program is, at the time of this, not completely 
reliable and thus all Guinier regions were determined and fitted manually. 
Since Rg is simply the root of squared distances, impure samples may also display linear 
Guinier regions, and thus the Guinier plot is not suited to determine sample purity. 
5.3 Pair distribution function (P(r)) 
 
Central to SAXS is the pair distribution function P(r), similar to the Patterson function in X-ray 
crystallography (Putnam et al., 2007). The P(r) function is related to the scattering intensity 
as follows: 
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and represents the histogram of distances between pairs of scatterer within a particle (Koch 
et al., 2003). The P(r) function is used to determine the Dmax value, the maximum intra 
molecular distance (Koch et al., 2003). In theory the P(r) function will obtain a value of zero 
at r = 0 and at r > Dmax (Koch et al., 2003). The calculation of a P(r) function is required for the 
3d ab initio modelling of scattering data (Mertens and Svergun, 2010). 
A P(r) function can be translated into simple overall shapes, some examples of these shapes 
and their corresponding P(r) functions are shown in Figure 5.5.  
 
Figure 5.5: Scattering intensities and pair distribution functions of common geometrical bodies with the 
same Dmax values. (A): Scattering intensities. The curves describing the spherical and dumbbell conformations 
are ideal, in practise they will appear much smoother. (B): P(r) function. Elongated particles peak at an early r 
value corresponding to the cross section of the particle. Figure as published by (Putnam et al., 2007). 
5.3.1 Considerations 
 
The P(r) function requires input concerning which data points to include and what Dmax value 
to use. The data range used usually begins with the first data point used to determine the 
Guinier region to filter out data corrupted by interparticle interactions, and ended when 
noise levels are too high. The Dmax value is determined manually on a simple trial and error 
basis. There is still no universal accepted approach for the creation of P(r) functions. For this 
reason the obtained Dmax value should be interpreted with care. 
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5.4 Ab initio modeling 
 
The purpose of ab initio modelling is to convert a one dimensional SAXS scattering curve into 
a three dimensional solution model. 
Initially a sphere with diameter equal or slightly larger than Dmax is filled with smaller beads 
(Mertens and Svergun, 2010). Each of these beads may either belong to the particle or to the 
solvent; these two states are indexed 1 and 0 (Koch et al., 2003). Starting from a distribution 
in which the entire sphere is packed, the model is modified to find the model that best fits 
the experimental data (Koch et al., 2003). Usually programs employ different types of Monte 
Carlo algorithms for this model fit (Koch et al., 2003). In a multicomponent system that 
contains components with distinctly different scattering lengths, such as a DNA binding 
proteins, it is possible to assign even further index values (solvent = 0 Protein = 1 DNA = 2) 
allowing the ability to distinguish the shape of the different components (Koch et al., 2003). 
In practice ab initio model fit is achieved through simulated annealing (Mertens and Svergun, 
2010). Random modifications are made to the system by changing index values, these 
changes will either move the theoretical scattering closer or further away from the 
experimental curve (Koch et al., 2003). Initially changes either way will be accepted but as 
the system is “cooled” the chance of accepting the second type of result will decrease (Koch 
et al., 2003). 
The ab initio models created in this thesis work were produced by the program DAMMIF, 
from the ATSAS program suite for ab initio modelling. The approach for this program is as 
follows(Svergun, 1999).  
1) Start from a spherical configuration in which d = Dmax and at a high temperature T0 
2) Select a bead at random, change its index value (from 0 to 1 or vice versa) and 
compute ∆ = f(confignew)-f(configold) 
3) If ∆ < 0 always accept confignew; if ∆ > 0 accept confignew with probability exp(-∆/T) 
otherwise accept configold. Repeat step 2 with the accepted configuration. 
4) Keep T constant for 100 reconfigurations or 10 successful reconfigurations whichever 
comes first, and then cool the system (Tnew = 0.9 * T) and repeat from step 1. 
Continue cooling until no further improvement in f(config) is observed. 
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In order to decrease the number of possible structures, various constraints are imposed on 
the program such as penalties for unconnected or unpacked beads (Svergun, 1999). The 
bead model procedure is shown in Figure 5.7. 
 
 
Figure 5.6: ab initio modelling in the program DAMMIN. Modelling of a helical oligomer in DAMMIN. (a-d) 
represents 1, 10, 50 and 120 iterations respectively. The beads accepted in the structure are shown in pink, 
their resulting scattering curve is shown in red. The experimental scattering curve is shown in green. The model 
was accepted after 120 iterations. To increase speed a packing radius of 10 was used resulting, this results in 
much fewer beads than normally used. Only a small portion of the curve is fitted. DAMMIN is similar to 
DAMMIF but contains a graphical interface and was used for illustrative purposes. The Figure was produced 
using elongated insulin oligomers.
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Figure 5.7: Examples of ab initio generated models: Models and crystal structures of thioredoxin (left) and 
reverse transcriptase (right). The light blue dots indicate the initial search volume. The yellow dots are the 
model determined by DAMMIN. The blue lines are the structures determined by X-ray crystallography. Figure 
adapted from (Svergun 1999).
 
 
5.4.1 Considerations 
 
Using a priory knowledge about the structure, various constraints, such as symmetry, can be 
introduced into the model. While this can generate models which appear to be of higher 
quality they may not reflect the real structure. Figure 5.7 depicts some solution structures 
obtained from SAXS experiments along with the relevant crystal structures superposed. 
These envelopes are of high quality, and are the best one can expect to be able to produce, 
without the introduction of constraints. 
In the modelling procedure it is possible to use beads of different sizes. Smaller beads 
increase the resolution of the resulting envelope but increases the required simulation time. 
Larger beads have the opposite effect. While it may be tempting to use very small bead 
sizes, the final model resolution is usually limited by the quality of the scattering curve.  
DAMMIF will attempt to model any P(r) function and does not have the functionality to 
recognize a polydisperse sample. 
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Usually twenty envelopes are determined and averaged. If envelopes show too large a 
discrepancy from the average envelope they are discarded. Ab initio envelopes should 
always be critically evaluated, especially if samples are suspected of being polydisperse. 
Even small amounts of aggregated proteins will cause the generation of an invalid model. 
5.5 CRYSOL fitting of experimental and theoretical scattering curves 
 
CRYSOL enables one to derive a theoretical scattering curve from a known crystal structure, 
to compare this to an experimental scattering curve and to calculate a deviation in form of 
the χ2 value (Svergun et al., 1995). CRYSOL thus allows one to test if a scattering curve 
matches a known crystal structure. Due to the flexibility of a protein in solution, the 
experimental scattering curve will rarely completely match the derived scattering curve. 
The χ2 is calculated as: 
 
   
 
   
  
               
     
 
                   
In which N is the number of experimental points, c is a scaling factor and σ(sj) is the 
experimental error at the momentum transfer sj (Petoukhov and Svergun, 2005). 
χ2 values should be interpreted with caution; if the errors in the measurements of the 
experimental data are high this will result in a low χ2 value. Thus scattering curves of poor 
quality will appear to resemble known crystal structures much more frequently than high 
quality structures. This also impairs comparisons between different experimental curves in 
which the error values will be different. CRYSOL also adds a hydration shell to the crystal 
structure. 
5.6 Rigid body modeling 
 
If a complex consists of K subunits with known structure and their partial scattering 
amplitudes can be denoted    
       and the scattering intensity of the entire complex can be 
described as: 
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As is the case with ab initio modelling, simulated annealing is applied in rigid body modelling. 
While several programs can be used for this purpose, in this thesis work only the program 
SASREF was used. The program starts with a fixed initial assembly of the K subunits and 
computes the scattering intensity of the complex using the above equation. Each subunit is 
then rotated by an arbitrary angle and shifted along an arbitrary direction and a new 
scattering intensity is calculated. The rigid body fitting of known models to experimental 
SAXS curves, the following function is minimized. 
                                                          
Here χ2 is calculated as in equation 5.7 and penalty values are added for disconnects (Pdis), 
crossovers (Pcross) and lack of continuity (Pcont) (Petoukhov and Svergun, 2005). 
SASREF adds hydration shells individually for each subunit whereas CRYSOL adds a hydration 
shell for the entire particle. This causes SASREF and CRYSOL fits to give different χ2 values for 
the same identical structures and SASREF models should thus have their χ2 value 
recalculated in CRYSOL for comparison purposes. 
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